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Abstract 
Introduction: Adolescent idiopathic scoliosis (AIS) is a complex three-dimensional 
structural deformity of the spine in adolescence. The worldwide prevalence rate is 
about 2-4%. Despite intensive research in this field, the etiopathogenesis of the 
disease still remains unknown. Scoliosis could progress and cause cosmetic and 
psychological problems in adolescent patients or even complications such as 
cardiopulmonary failures in severe cases. Current treatments for scoliosis include 
observation, bracing and corrective surgery with instruments. However, these 
treatments are not satisfactory as they are treating the phenotypical problems of 
spinal deformity but not the etiology. The possibility of curve progression with 
bracing and surgical complications still existed. Therefore, it is crucial to understand 
the etiopathogenesis of AIS in order to look for better preventive measures, 
prognostication and targeted treatment for symptomatic or high-risk groups. 
It is generally believed that growth is closely associated with the occurrence and 
development of AIS. Previous studies have reported a different anthropometric 
phenotype in AIS patients, such as lower body weight, lower body mass index, higher 
corrected height and arm span, which indicated the existence of abnormal systemic 
skeletal growth in these adolescences during the peripubertal rapid growth phase. 
However, the exact role of growth in the development of scoliosis still remains 
obscure; On the other hand, it was suggested by numerous studies that melatonin, 
the main product from the pineal gland, plays a key role in the etiology of AIS. Animal 
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studies showed that pinealectomy could lead to scoliosis-like deformity in avians and 
rodents and the administration of melatonin could prevent scoliosis development in 
these pinealectomized models. Other studies discovered a signaling pathway 
dysfunction in the osteoblasts of AIS patients and some suggested that this might be 
due to the abnormal expression of melatonin receptor IB. Genetic association study 
also showed that melatonin receptor I B polymorphism is associated with the 
occurrence of AIS; Melatonin can affect proliferation and differentiation of osteoblast 
and hence bone growth, metabolism and mineralization. It also has influence on 
growth hormone, one of the main regulators of growth during puberty. Therefore, it 
is postulated that the abnormal growth in AIS patients is closely related to melatonin 
signaling dysfunction. The aim of this study was to study the role of growth in 
scoliosis development as well as its relationship with melatonin signaling. The 
anthropometry of AIS patients was first studied longitudinally. Then a local 
melatonin-deficient induced scoliotic animal model was established to investigate the 
early growth pattern before the onset of scoliosis and its relationship with melatonin 
signaling deficiency. Finally, the expression of melatonin receptors in osteoblast of 
AIS patients and normal controls was compared to investigate the melatonin 
signaling dysfunction in AIS. 
Methods: First part of the study 611 AIS girls and 296 healthy controls were 
recruited and among them, 194 AIS girls and 116 healthy controls were followed up 
until skeletal maturity. The AIS girls were grouped into moderate (AIS20) and severe 
curve (AIS40) groups according to their maximum curve magnitude of the major 
curve at skeletal maturity. Clinical data and detail anthropometric parameters were 
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recorded. In the cross-sectional analysis, the groups of subjects were compared 
within different age groups (from age 12 to 16). In the longitudinal study, linear 
mixed modeling with adjustment on age and year since menarche was employed to 
formulate the growth trajectory of different anthropometric parameters between 
age 12 and 16. In the second part of the study, a pinealectomy induced scoliotic local 
chicken model was established. The growth and growth pattern of pinealectomized 
and sham chickens was monitored for 5 weeks longitudinally after operation by 
measuring tibia length and weight twice a week. For the study on melatonin 
receptor expression, osteoblasts were isolated from intra-operative bone biopsies 
from 41 AIS girls undergoing corrective spinal surgery and 9 control subjects 
undergoing unrelated post-trauma reconstructive surgery. Protein and mRNA 
expression of melatonin receptor l A (MTNRIA) and I B (MTNRIB) was compared 
quantitatively between AIS and normal by Western blotting and real time polymerase 
chain reaction. Correlation of the expression level of melatonin receptors with the 
anthropometric parameters was then analyzed for AIS subjects. 
Results: In the clinical study, it was observed that AIS patients had a longer arm span, 
greater corrected body height, lower body weight and BMI, and delayed menarche. 
The growth rate of severe AIS girls was faster than that of moderate AIS girls and 
normal controls even after adjustment for sexual maturity and the growth patterns 
were different between groups. For the animal study, pinealectomy could 
successfully induce scoliosis in a local breed chicken and none of the sham chickens 
developed scoliosis. An abnormal growth rate pattern was observed only in 
pinealectomized chickens which showed a M-shape-like growth rate pattern (a 
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sudden drop in growth rate followed by an increase with two peaks) before the onset 
of scoliosis. The study on expression of melatonin receptor found that both the 
protein and mRNA expression of MTNRIB were significantly lower in AIS patients 
while no difference was found for MTNRIA. The clinical evaluation on these patients 
also showed that the patients with low expression of MTNRIB had a significantly 
longer arm span. 
Discussion: This is the first report on the abnormal skeletal growth and growth 
pattern before onset of scoliosis in a scoliotic animal model. The melatonin-deficient 
status of the scoliotic chickens implied that melatonin might be related to the growth 
and the occurrence of scoliosis. The lower expression of MTNRIB in AIS patients and 
its correlation with the arm span suggested the presence of melatonin signaling 
deficiency and its possible relationship with growth. Abnormal skeletal growth and 
growth pattern was found in AIS patients, particularly in those with severe curves 
even after adjustment with onset of menarche. The findings of this series of studies 
demonstrated the importance of melatonin in skeletal growth and the 
etiopathogenesis of AIS. 
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1.1 General Overview of Adolescent Idiopathic Scoliosis (AIS) 
Scoliosis is one of the most common deformities of the spine. By definition, it is a 
complex three-dimensional structural lateral deformity of the spine with vertebral 
rotation (Figure 1.1) (1). Scoliosis can be diagnosed by forward bending test and 
confirmed by X-ray radiography. The severity of the curve is then assessed by 
measuring Cobb angle. A lateral curve with an angle greater than 1 0 � i s defined as 
scoliosis (1). The disease can be classified by its etiology: congenital, neuromuscular, 
neurofibromatosis, mesenchymal disorders, trauma, etc. However, over 80% of the 
scoliosis cases are of unknown reasons and therefore termed idiopathic scoliosis (2). 
Idiopathic scoliosis can be further classified by the time of onset: infantile (age below 
3 years old), juvenile (age 5 to 8 years old), and adolescent (age 10 years old to 
skeletal maturity) (3). Adolescent idiopathic scoliosis (AIS) is the most common type 
among these three. Scoliosis can be further described according to the pattern and 
curvature's apical region such as cervical, thoracic, thoracolumbar and lumbar curves 
after radiographic assessment. For pre-surgical planning, different types of scoliosis 
were defined by the King classification (4) conventionally. However due to poor 
inter-observer variability (5, 6), a new system developed by Lenke et al. (7) was 
widely adopted later. In addition to the classification of curve type, this new system 
also includes a lumbar spine and a sagittal thoracic modifier, which greatly improves 
the inter-observer and intra-observer reliability (7). 
The incidence of AIS, by the definition of a lateral curve great than 1 0 � � v a r i e s from 2 
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to 13.6% among different countries and ethnic backgrounds (8-15). In Hong Kong, 
the prevalence of AIS is about 3% (16). The female-to-male ratio for the occurrence 
of scoliosis is similar for small curves of 10� (14) . However, this ratio increases with 
the curve severity. The ratio rises from 1.5 to 1 for curves below 20° to 5.4:1 for 
curves greater than 2 0 � a n d to 10:1 for curves over 3 0 � ( 1 4 , 15). In addition, the 
female-to-male ratio requiring treatment is 7:1, with approximately 0.1% warranting 
the need for corrective surgery (17). Although less than 10% of epidemiological 
studies truly reported that positively screened scoliosis would require any treatment, 
those in need of attention would benefit from a better understanding of the etiology 
of this disorder (13,14,18-20). 
1.2 Natural History 
The natural history of AIS is indispensable for the decision on treatment option as 
well as facilitating the research on the etiopathogenesis of the disease (21, 22). 
Previous studies reported that both the severity and the type of the curve are 
correlated to the possibility of progression: Curves less than 30° Cobb at the 
beginning would not progress in general but the risk of progression increases with 
the Cobb angle (23-27). In addition, curve patterns like double curves or a lumbar 
curve increase the risk of progression (20). It was also reported that right major 
thoracic curve has the greatest tendency to progress (28). 
Curve progression also depends on growth potential and sex (28-31). Pre-
menarcheal girls and patients with Risser grade 0 were found to have a higher risk of 
curve progression (32, 33). The possibility of progression is also greater in girls when 
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compared with maturity- and age-matched boys (18, 20, 34, 35). 
A 50-year follow up study on 117 untreated AIS patients (22, 36) showed that the 
mortality rate of scoliotic patients is similar to other normal adolescents in the 
population. The differences could only be observed in patients with a thoracic curve 
greater than 80° Cobb, as it increases the risk of failure of pulmonary function. The 
risk of respiratory failure is significantly higher than normal only in AIS patients with 
a predicted low vital capacity (< 45%) and a large scoliotic angle (> 110") (37, 38). 
In the same 50-year follow up study by Weinstein et al. (36), it was found that both 
chronic and acute back pain were more likely to occur in these patients than controls. 
The pain severity is associated not with the curve size (39), but with the curve 
pattern (20). Patients with thoracolumbar curves reported a greater back pain than 
those with double curves (40). However, the ability to work and perform everyday 
activities in patients with AIS was not significantly limited when compared with 
normal controls (22). 
Shortness of breath is another common discomfort reported from scoliotic patients 
(34, 38). It is more serious in patients with a thoracic curve greater than 8 0 � C o b b , 
large degree of apical vertebral rotation near rib cage, hypokyphosis and Cobb angle 
greater than 5 0 � a t skeletal maturity. Double curves with large degrees may also be 
an independent risk factor {22, 34, 41). 
Other physical and health impairments, like hypertension (38) and neurological 
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impairment (42), are seldom reported. However, AIS may result in psychological 
discomfort such as low self esteem in patients (22). Significance is seen when 
comparing younger female AIS patients with small curves and their age-matched 
control (43). 
1.3 Current Treatments 
Current medical treatment for AIS includes observation, bracing (non-operative) and 
surgical treatments. The choice of treatment is affected by many criteria such the 
age of the patient, skeletal maturity, curve type, severity of curvature and 
progression status. The best treatment is employed to prevent the curve from 
deterioration and improve cosmetic appearance. 
1.3.1 Non-operative Treatments 
Non-operative treatment of scoliosis includes observation and bracing. In general, 
observation with regular follow-up can only be adopted for skeletally immature 
patients with Cobb angle below 2 0 � o r below 40° for skeletally mature patients (44). 
However, difference in medical practices and measurement methods among 
clinicians may cause misinterpretation of the actual curve angle (45) and may delay 
the time for any necessary treatments. 
For other cases, bracing is usually recommended by clinicians to prevent curve 
progression so to avoid the need for surgery. There are three common braces: 1. 
Milwaukee (46) for patients with apex higher than T8 (47, 48); 2. Charleston bending 
(49, 50) which is worn at night with higher flexibility; and 3. thoracolumbosacral 
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orthosis (TLSO) (51, 52), an underarm brace which encloses the lower rib cage for 
patients with apex from T8 downwards. 
It was shown in previous studies that full time bracing in a proper way can effectively 
control curve progression in skeletally immature AIS girls with Cobb 25-35� (53, 54) 
and it is most effective when patients wear the braces for up to 20 hours per day 
(55), though the effectiveness of bracing could not be seen in patients with little 
growth potential. A study by the Scoliosis Research Society (54) and also a review on 
Milwaukee bracing (56) demonstrated that bracing was successful in controlling 
curve progression. However, doubt was casted on the efficacy of bracing in 
preventing curve progression recently. It was found that the rate of surgery after 
bracing could not be significantly reduced compared with those after observation 
only (22). 
Bracing could bring negative impacts to patients' quality of life and psychological 
status. The stiffness of the brace might bring discomfort and fatigue to AIS patients 
(57-59). A cross-sectional study on the type of bracing (Milwaukee, Boston, 
Charleston bending and TLSO braces) on health status (60) showed that the negative 
impact of bracing was the greatest in patients using Milwaukee brace, in terms of 
psychosocial functioning and back flexibility. 
1.3.2 Surgical Treatments 
The aim of surgery is to prevent further progression as well as to correct spine 
deformity or minimize curve angle. Besides, it could also restore trunk balance and 
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improve cosmetic appearance. Curve severity and pattern and skeletal maturity are 
the main factors that decide whether surgery is necessary. Generally, patients having 
a thoracic curve with Cobb angle greater than 45° and a high risk of progression 
would be recommended for a corrective surgery (61). 
The three main approaches of surgical correction of scoliosis are posterior, anterior 
and combined anterior-posterior. The best approach is adopted after the assessment 
of curve type and severity. During the surgery, spinal instrumentation will be carried 
out to correct the curve followed by bone graft for fusion to prevent the progress of 
scoliosis afterwards. The fusion of spine usually becomes solid within six months to 
one year post-operatively and the patients could resume normal life and activity. It 
had been proved that the pulmonary function of AIS patients could be restored after 
the surgery as their vital capacity increased from 67% to 84% (37). 
However, it is possible that the deformity of the spine could not be completely 
corrected by surgery or even continues to deteriorate afterwards. It has been 
reported that curve progression occurred particularly in the young patients before 
skeletal maturity {62, 63). One of the explanations is the asymmetrical growth of the 
anterior and posterior spinal growth plate as the patients were still at their rapid 
growth phase {62, 63). The kind of curve progression after spinal fusion is known as 
'crankshaft phenomenon'. 
In conclusion, the treatments for AIS at present are still not satisfactory and cannot 
completely correct the deformity. Besides, prognostic factor for the prediction of 
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onset and curve progression is very much in need to allow the employment of 
suitable treatments at an early stage. Therefore, it is crucial to have a 
comprehensive understanding of the etiology of AIS to develop alternative 
treatments and to look for a useful prognostic factor. 
1.4 Current Hypothesis on the Etiology of AIS 
1.4.1 Genetic Factors 
The role of hereditary or genetic factors in the development of AIS is widely 
accepted (64-75). It has been documented by multiple studies that the incidence of 
scoliosis within families is higher than the general population. Kesling and Reinker 
(73) found that the concordance rate of AIS is 73% in monozygotic twins and 36% in 
dizygous twins. The higher concordance rate in monozygotic twins than dizygotic 
twins was also consistently shown in other studies (64, 73, 74, 76-82). Familial 
studies by Harrington (83) found a 27% incidence of scoliosis in girls whose mothers 
exhibited scoliotic curves greater than 15�. Ogilvie et al. (84) found that, among the 
131 cases of AIS he studied, 97% had a familial origin. 
Besides the occurrence of scoliosis, it was also found that there was a high 
consistency between monozygotic twins in terms of the direction of curve, level of 
the apex and kyphotic angle (81, 85, 86). These evidences suggested that both the 
occurrence and phenotypes of AIS were affected by genetic factors. 
To date, there was no consensus on the mode of inheritance of AIS. Some authors 
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suggested an autosomal dominant mode (64), X-linked inheritance (65, 72) or a 
dominant major gene diallele model (70). Others proposed a multi-factorial 
inheritance pattern, which could explain the wide spectrum of scoliosis occurrence 
among individuals and their families (74). 
Multiple genome-wide linkage analysis revealed many different gene loci that were 
linked to AIS (71, 75, 87-90). In 2005, Miller et al. (91) carried out a genomic 
screening of 202 families with at least two individuals diagnosed with idiopathic 
scoliosis and identified several candidate regions in chromosome 6, 9, 16, and 17. 
The candidate regions identified by the studies above covered nearly half of the 23 
chromosomes, which displayed the heterogeneity of familial AIS. 
Candidate genes were also selected and their single nucleotide polymorphisms (SNPs) 
were studied in AIS patients and controls. The genes were selected based on the 
observed phenotypes of AIS. Some genes were found to be associated with the 
occurrence of AIS including melatonin receptor I B (92), estrogen receptor alpha (93) 
and beta (94), interleukin 6 (IL-6) and matrix metallopeptidase 3 (MMP3) (95). While 
some others were associated with the curve severity, e.g. insulin-like growth factor-1 
(IGF-l) (96), estrogen receptor genes (93, 94, 97, 98), and matrilin-1 (99). However, 
the association was not found in some replicated studies in other populations (100). 
Therefore, further studies are required to confirm the positive findings. 
The complex nature of AIS and its high degree of heterogeneity may explain the 
inconsistent results of genetic studies. It was observed that familial AIS girls had 
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different curve severity and longer arm span than sporadic AIS girls (101). The study 
reflects the underlying differences in the genetic composition between the two 
groups. Further sub-grouping or stringent criteria of selection of AIS subjects is 
necessary for comprehensive and reliable genetic analysis. 
1.4.2 Neuromuscular Impairment 
It has been found that the incidence of neurological impairment is higher in AIS 
patients such as abnormal Somatosensory Evoked Potential (SSEPs) (83, 102) and 
syringomyelia (103). Besides, Chu et al. (104) reported that tonsillar ectopia was 
observed in 42% of the 69 AIS subjects from MRI. These patients had tonsillar trips 
below the BO line (The line connecting basion and opisthion). Apart from the low-
lying tonsil, Chu et al. (104) also found spinal cord tethering occurred in severe AIS 
patients which was probably due to the curvature. The results indicated that there 
was disproportionate growth between the neural and skeletal system in AIS. 
The regional brain volume was also found to be significantly different between AIS 
patients and age-matched control (105). Out of the 22 regions measured, 10 were 
larger in AIS patients while the remaining regions were smaller than control. The 
poor performance in visual testing and balance impairment reported in AIS patients 
previously (106,107) may be explained by these findings. 
The development and stability of the spine also depends on extrinsic factors such as 
muscle force and elasticity of tendons (108). Several studies reported that muscular 
diseases were associated with the occurrence of secondary scoliosis deformity (109-
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112). The muscle imbalance between the left and right sides has also been 
associated with the etiology of AIS (113, 114). A study on the muscle of AIS patients 
showed that the middle and deep dermis muscle of AIS was significantly different 
from that of normal healthy subjects (115). A histoenzymologic experiment from the 
same study demonstrated that the patients also had an abnormal predominance of 
type I muscle fibers. These results proved that the anatomical structure in AIS 
patients was different. At the molecular level, Cheng et al. (116) discovered that 
there was a lower expression of glycoproteins in the iliac crest biopsies from AIS 
patients. While Moreau et al. (117) found a higher mRNA expression level of 
restricted genes on the left side of the paraspinal muscle obtained from AIS patients 
intra-operatively. The dominance of the right thoracic curve over the left curve can 
be explained by this observation (118). However, the impairment of muscle 
development or any abnormalities are very likely to be a secondary instead of a 
primary cause of spinal deformity. 
1.4.3 Abnormalities in Skeletal Development 
Both abnormal bone growth and skeletal disproportion have been associated with 
the pathogenesis of AIS (119) as well as its development (120). Numerous studies 
had reported that AIS patients were different from normal controls in many 
anthropometric parameters (121-130). These included shorter body height, arm 
span, sitting height, and leg length. A large-scale cross-sectional studies on 598 AIS 
girls and 307 age-matched control carried out by Cheung et al. (131) found that the 
differences of the above parameters were statistically significant, even after 
adjusting for maturity, as AIS patients often have a delayed menarche. Besides, 
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significant correlation of the curve severity versus arm span was found, proving that 
the abnormal bone growth in AIS patients is closely related to the development and 
progression of scoliosis. Study by Guo et al. (132) reported that AIS girls had longer 
vertebral bodies and shorter pedicle height between T1 and T12 vertebrae when 
compared with normal controls. While Wang et al (133) found that the radius 
dimension ratio, derived from the ratio of radius diameter to radius length, was 
significantly lower in severe AIS cases. These results suggested that AIS patients had 
a systemic disproportional growth. Studies on skeletal growth of AIS patients and 
their results will be discussed in detail in later sessions. 
1.4.4 Metabolic Dysfunction 
Metabolic dysfunction is generally believed to be one of the etiologies of AIS (134). 
It is reflected by several phenotypic abnormalities in AIS such as lower bone mineral 
density (135) and delayed sexual maturity (136). As a result, different hormones had 
been studied for the association with AIS, namely growth hormone, leptin, and 
melatonin. 
1.4.4.1 Lower Bone Mineral Density 
Lower bone mineral density (BMD) in AIS patients was first reported by Burner (137). 
This observation was then repeatedly reported by other authors (64, 138-141). 
Cheng et al. (138, 142) measured the bone mineral density in AIS patients by dual-
energy X-absorptiometry (DXA) at lumbar and proximal femoral head. It was found 
that 33.3% girls with AIS showed osteopenia and a lower BMD between 6.9 - 30.4% 
in all measured regions. Low BMD was also found in both cortical and cancellous 
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bone in the proximal radius as measured by peripheral quantitative computed 
tomography (pact). Moreover, in a longitudinal study of BMD of 14 AIS patients with 
more severe osteopenia (142), the Z-score of the patients decreased from -2.96 to -
3.84. This suggested that osteopenia in AIS is a persistent problem of bone 
metabolism and may develop into osteoporosis in late adulthood. 
The lower femoral BMD in AIS is unlikely to be secondary to the spinal deformity and 
asymmetrical mechanical loading of the hips and spine, as Cheng et al. (138) and 
Cook et al. (139) showed that there was no difference in the proximal femoral BMD 
of the two hips between AIS patients and normal healthy controls. 
Low BMD in AIS patients may be the result of abnormal bone mineralization 
together with increased bone growth during puberty. A higher bone turnover and a 
relative low calcium intake were found in AIS patients when compared to normal 
controls (116, 143). Besides, sexual maturation showed a significant relationship 
between early menarche and higher peak bone mass (144), and Hung et al. (136) 
reported a general delay of menarche in AIS patients. It was speculated that during 
the rapid growing peri-pubertal period, the mechanically weakened spinal column of 
the AIS patients with osteopenia would be more prone to scoliosis development. 
The lower BMD could also be a prognostic factor of curve progression in AIS. A 
longitudinal study on BMD of AIS girls until reaching skeletal maturity (136) found 
that the prevalence of curve progression could be predicted by statistics. 
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1.4.4.2 Delayed Sexual Maturity 
Puberty in normal adolescents can be indicated by chronological age, height and 
weight variation, skeletal growth and sexual maturation (145). It has been suggested 
that the progression of scoliosis in adolescence was associated with the maturity 
status (146, 147). It is common to use indicators such as Risser signs, chronological 
age and age at menarche for the assessment of maturity in scoliotic patients (145). 
However, Risser sign was shown to be poorly correlated with the curve progression 
phase (148). Another effective sexual maturity indicator is yet to be found for the 
prediction of progression of scoliosis. 
A study carried out by Goldberg et al. (147) discovered that the age of menarche in 
AIS girls was shifted significantly 0.39 years earlier than the general population with 
the same ethnic background. In addition, AIS girls with an early menarche tended to 
have a stable curvature while those with a late onset tended to progress. Other 
research on menarche of AIS girls gave similar results (149). Though the late onset of 
menarche in AIS girls matched with the clinical observations that they are taller and 
slender (131), stronger evidences are still necessary to confirm the relationship 
between menarche and growth disturbance. 
1.4.4.3 Hormonal Dysfunction 
Several studies reported a higher plasma growth hormone (GH) and serum 
somatomedin A levels in AIS girls than age-matched controls (150). Skoglund and 
Miller et al. (151) also observed this difference. Besides, they found a significantly 
higher sensitivity of GH release mechanism in prepubertal AIS girls. Another study 
14 
(152) found that growth hormone treatment over a 10-week period in AIS girls 
created a more rapid thoracic curve progression and the curve remained stable 
when the treatment terminated. On the contrary, Ahl et a丨.(149) did not observe 
any difference in the growth hormone level between AIS girls and control in pubertal 
stages 3 and 4. However, the difference was found in subjects at pubertal stage 2. 
The study by Misol et al. (153) also showed no differences in growth hormone levels 
between AIS patients and controls following glucose-tolerance test and insulin-
induced hypoglycemia. The genetic study by Qiu et al. (154) reported that the 
growth hormone receptor did not appear to be a predisposing gene or disease 
modifier gene in AIS. The contradictory results of these studies imply the necessity 
of further studies on growth hormone and the etiology of AIS. 
Another hormone shown to be associated with AIS is leptin (134). Leptin is a 
regulator of energy expenditure in females and plays an important role in body 
growth and development particularly during childhood and adolescence (155, 156). 
Qiu et al. (157) revealed that circulating leptin level in AIS girls was significantly 
lower than the age- and sex-matched control even after adjusting for menstrual 
status. Moreover, it was found that leptin was positively associated with body 
weight, BMD, BMI and other growth parameters (157). It was hypothesized that 
hypothalamic dysfunction with altered hypothalamic sensitivity to leptin through a 
sympathetic nervous system-driven asymmetric effect may create skeletal length 
asymmetries as well as influencing BMI and skeletal maturity. Recently, a hormone 
with increasing interest in the field of AIS is melatonin, as its deficiency has been 
linked with the occurrence of AIS (134). Melatonin is a hormone secreted primarily 
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from the pineal gland (158). This hormone and its relationship with AIS will be 
described in detail in later sections. 
1.5 Skeletal and Spinal Growth in AIS 
1.5.1 Abnormal Growth during Puberty 
It is generally believed that the onset and curve progression of AIS are closely related 
to growth (35, 159). A lot of analyses on the anthropometry of AIS girls showed that 
they are taller and leaner than healthy controls (12, 131, 146, 160, 161), while some 
could not show any significant difference (162, 163). The negative results observed 
by some studies might be due the limitation in sample size (both AIS and controls), 
lack of detailed anthropometric measurements and inadequate information on the 
pubertal status. Nissinen et al. (164), in their 11-year follow-up study, showed that 
the body height, sitting height and growth of sitting height were higher in pre-
scoliotic children, though the difference was not significant towards the 
development of AIS. Another large-scale study by Cheung et al. (131) revealed that 
AIS girls were significantly taller, in terms of both height and sitting height, and had a 
longer arm span when compared with their pubertal status-matched control. 
Other authors tried to prove the existence of abnormal growth in AIS from another 
aspect. Zorab et al. (165) found that the total urinary hydroxyl proline excreted from 
AIS patients was higher than normal. A higher urinary hydroxyl proline 
concentration indicated a higher turnover of bone collagen, corresponding with 
increased bone growth and repair. The results suggested that there was either an 
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increase in bone growth or bone remodeling in AIS patients. When Clark et al. (166) 
tried to repeat the experiment on 21 AIS patients and normal controls, he found no 
difference between the two groups. Growth hormone is another indicator of growth 
which had been studied for the association with AIS (150). Also, fluctuations in 
growth hormone have been mentioned to be a causative factor in the development 
of AIS. However, the results were controversial. While Willner et al. (150) showed a 
higher basal growth hormone and somatomedin-A in serum samples of AIS patients, 
other authors failed to observe any difference in these two indicators between AIS 
and controls (153,167). 
Despite the conflicting results from different centers, it is quite certain that AIS 
patients are generally taller and more slender than normal controls. This indicates 
an abnormal growth with a faster rate in AIS patients, which may be related to the 
likelihood of development and progression of scoliosis. 
1.5.2 Growth Pattern 
Adolescents experience rapid growth during their puberty which has been 
recognized as a key factor of the etiopathogenesis and curve progression of AIS (35, 
159). The difference in growth pattern of AIS girls during their peri-pubertal stage 
was observed in several studies. In a longitudinal study (168), girls with AIS showed a 
higher peak height velocity which was followed by a rapid sharp decline. The 
acquaintance of the timing of peak height velocity also allowed the prediction of 
scoliosis progression much more accurately than other maturity scales. Another 
large cross-sectional study (70) observed that AIS girls were taller initially at a young 
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age but the difference in height disappeared during the later phase of growth. The 
authors suggested that girls with AIS are running growth trajectories but then caught 
up by their normal peers towards the end of growth. On the other hand, some 
studies showed that AIS girls were constantly taller (21, 149, 169-172). The 
inconsistency in the observations was probably due to the cross sectional nature of 
these studies. Some authors suggested that the growth rate is important in the 
development of scoliosis and growth spurt and peak height velocity were important 
factors in predicting scoliosis development and progression (35). However, the 
measurements of height and calculation of peak height velocity are difficult to carry 
out in practice. 
1.5.3 Disproportional Growth in AIS 
The abnormal growth of spine in AIS during puberty is believed to be contributed by 
abnormal vertebral growth (173). The height of the sixth thoracic vertebra was 
found to be significantly taller in the AIS patients. The height-to-width ratio at their 
sixth thoracic level was also greater than normal spines. Studies on differential 
growth of the anterior and posterior elements of the thoracic vertebrae by Guo et al. 
(132, 174) revealed a longer vertebral body between T1 and T12 in the anterior 
column and shorter pedicle heights with longer inter-pedicular distances in the 
posterior column in AIS patients by MRI. Besides, the curve severity was correlated 
significantly with the ratio of vertebral body length to pedicle height at ail thoracic 
levels. The longitudinal growth of the vertebral bodies in AIS patients was faster and 
mainly contributed by endochondral ossification while their circumferential growth 
by membranous ossification is slower in both the vertebral bodies and pedicles. 
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Therefore, it was postulated that uncoupled endochondral-membranous bone 
formation has led to disproportionate anterior spinal growth in AIS, which may affect 
the initiation or progression of the deformity. 
Porter (175) measured the axial length of the anterior aspect of the vertebral bodies 
and the vertebral canal in skeletons and discovered that the vertebral canals are 
shorter than the vertebral column in scoliotic spines but not in the normal spines. 
The degree of discrepancy was correlated to the degree of rotation. 
Zhu et al (176) found a more active growth in the anterior column than posterior of 
vertebral endplate in AIS patients by histomorphometric study of the vertebral 
endplate of AIS patients. It is presumed that during the rapid growth phase of 
puberty, when scoliosis is most inclined to occur, the spine buckles with growth 
while the posterior elements consequently fail to catch up with the anterior growth 
in some adolescents. This results as a tether and forcing the spine into lordosis and 
the forward bending forces the apical vertebrae of this lordotic segment to translate 
to the side and leads to scoliosis consequently (177). 
Other than the spine, disproportionate endochondral-membranous bone growth 
was also reported in peripheral bone and skull base. Wang et al. (133) showed that 
the radius dimension ratio, derived from the ratio of radius diameter to radius length, 
was significantly lower in severe AIS girls than the controls and the ratio of AIS girls 
correlated with the curve severity. The results indicated a systemic disproportional 
bone growth in patients with AIS. 
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As far as 1968, Roth et al. suggested there was asynchronous spinal neuro-osseous 
growth in patients with idiopathic scoliosis (178, 179). He speculated that scoliosis is 
a disproportion of vertebro-neural growth due to either a short spinal cord or a too 
rapid growth of spine (178). Porter (175, 180, 181) tried to prove this theory with 
anatomical specimens and did find a shorter vertebral canal relative to the vertebral 
bodies in AIS. With the multiplanar MRI reformatting technique, Chu et al. (182, 183) 
was also able to observer a longer vertebral column length both in thoracic and 
whole spine in AIS with thoracic or thoracolumbar curve but the spinal cord was not 
lengthened accordingly. The ratio of cord to vertebral column length was also 
negatively correlated with the transverse diameter of the cord, the concave and 
convex lateral cord space (LCS), and cerebellar tonsillar level in AIS (183). 
Neurological dysfunction such as abnormal SSEP in some AIS patients may be 
explained by the relative tethering and increased tension along the longitudinal axis 
of spinal cord (183). These results support both the concept of asynchronous spinal 
neuro-osseous growth as well as the hypothesis of relative anterior spinal 
overgrowth. To account for these two phenomena, Burwell et al. (184) proposed a 
concept of normal neuro-osseous time of maturation (NOTOM) system. This system 
regulates the dynamic physiological balance of osseous and neuro growth and 
maturation. It is postulated that any disturbance to this physiological balance would 
lead to asymmetric growth of a rapidly growing and active spine of adolescent and 
result in spinal deformity. 
1.5.4 Asymmetric Growth 
Asymmetric growth of neurocentral cartilage (NCC), the growth plate cartilage 
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between the vertebral body and pedical, had been believed to be associated with 
the etiopathogenesis of AIS. A scoliotic animal model was developed by Beguiristain 
ef al., (185) using two-month-old pigs by epiphysiodesis of the neurocentral cartilage 
using cancellous screws. This model was confirmed later by Zhang et al. (186) as the 
authors found that either placing a single or double right transpedicular screws 
across the neurocentral synchondrosis from T7 to T14 could produce scoliosis. 
Histological analysis also confirmed the closure of neurocentral synchondrosis was 
greatest in the double-screw group, in which the occurrence of scoliosis was the 
highest, followed by the single-screw group. No closure was found in the control 
group, which did not develop scoliosis. These findings proved the importance of NCC 
in the development of scoliosis in an immature animal. However in human, the 
maximum activity of NCC is at 5-6 years old. The closure of NCC occurs at 6 years old 
in the cervical region, followed by the lumbar and then the thoracic (187-190). No 
significant pedicle growth in both AIS patients or control subjects by CT scanning was 
found (191). Therefore, it is not very likely that NCC is involved in the scoliosis of 
adolescents. 
Asymmetric rib length was found in patients with thoracic idiopathic scoliosis but not 
in normal females (192). A similar observation was found in rabbits with scoliosis 
produced by resecting the intercostals nerve on the right side, posteriorly or 
anteriorly (193, 194). Scoliosis was observed 6 months after the surgery with convex 
to the left combining apical vertebral rotation and rib cage deformity. It was 
suggested that the scoliosis was caused by asymmetric growth of the bilateral rib 
(195, 196), which might be due to the increased vascularity of one side (197). 
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Asymmetry in vascularity of the breasts was also reported in girls with right convex 
thoracic curve by thermographic and diaphanographic methods (198). However, 
with more advanced methods such as Doppler ultrasonography, Korovessis et al. 
(199) could not find significant asymmetry in the ultrasonographic parameters of the 
internal mammary artery between right and left sides in both AIS patients and 
controls. Though the haemodynamic flow parameters and anatomical parameters of 
the right and left internal mammary artery were significantly correlated with the 
magnitude of rib-vertebra angles, the difference was not observed in patients who 
experienced bracing (200, 201). This indicated that the asymmetry in haemodynamic 
flow parameters in thoracic AIS might not be the primary changes. 
Besides NCC and rib length, it was recently found that asymmetric growth occurred 
in human spine intrinsically. Castelein et al. (118) discovered that the predominant 
rotation of the human spine is to the left in higher thoracic vertebrae and to the 
right in the mid and lower thoracic vertebrae. The authors proposed that the 
directional rotational asymmetry in human could lead to the abnormal differential 
growth of pedicles and spine (202-205), which resulted in spine deformity and 
affected progression of AIS. However, the underlying mechanism of how asymmetric 
growth contributes to scoliosis is still unclear. 
1.6 Melatonin and its Receptor 
1.6.1 Introduction 
Melatonin (Figure 1.2), or N-acetyl-5-methoxytryptamine was first discovered by 
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Lerner et al. (206). It is found in many living organisms, including non-mammalian 
vertebrates, some invertebrates, and even plants (158, 207). Melatonin is secreted 
mainly from the pineal gland, and also from retina, extraorbital lacrimal gland, 
Harderian gland, gastrointestinal tract, blood platelets and bone marrow cells (158) 
in trace amounts. Its biosynthetic pathway (Figure 1.3) starts from the amino acid, 
tryptophan, taken up from the circulation, which is then converted by tryptophan 
hydroxylase to 5-hydroxytryptophan and further decarboxylated to serotonin. 
Melatonin can then be synthesized from serotonin with the catalytic help of two 
important enzymes: arylalkylamine-N-acetyltransferase (AA-NAT) and 
hydroxyindole-0- methyltransferase (HIOMT). AA-NAT catalyzes the conversion of 
serotonin to N-acetylserotonin and HIOMT, an enzyme mainly produced in the pineal 
gland, methylates N-acetylserotonin and gives the final product melatonin. 
Melatonin has a very short half-life as it is quickly metabolized by the liver. It is 
hydrolyzed to 6-hydroxymelatonin and then excreted in the urine as 6-
sulfatoxymelatonin (208). 
The circadian rhythm is regulated by the biological clock in the hypothalamic 
suprachiasmatic nucleus (SCN) (209), which is synchronized to the environmental 
light-dark cycle perceived by the retina. In darkness, the photoreceptors are 
unpolarized, a signal is then passed to the SCN and the adrenergic receptors in the 
pineal gland which is activated through the enzyme norepinephrine (210). This 
stimulation activates AA-NAT and allows the synthesis and release of melatonin to 
the bloodstream by passive diffusion (210). In human, the serum melatonin level 
gradually increases after the onset of darkness, reaching a peak at around 2:00am to 
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4:00am and decreases afterwards, to the lowest level at around 2:00pm. Besides the 
environmental light-dark cycle, seasonal variations of daylight hours and age also 
affect melatonin production. Both long summer and aging can depress melatonin 
secretion (177, 208). 
The physiological functions of melatonin in mammals include regulation of embryo 
development (211, 212), cardiac monitoring (213), circadian rhythm (214, 215), 
sexual maturation (216, 217), aging (170, 218), tumor malignancy (219-223) and 
bone growth (224-226). The regulation of circadian rhythms is one of the most 
critical functions in human. The administration of melatonin could shift the circadian 
rhythm in human (227, 228) and daily melatonin administration at normal bedtime 
hour could benefits the nocturnal sleep and daytime alertness in both blind and 
sighted subjects (229). 
1.6.2 Melatonin Receptor 
There are three types of melatonin receptors: M T l (or MTNRIA), MT2 (or MTNRIB) 
and MT3 (230). MTNRIA and MTNRIB were firstly cloned in 1994 and 1995, 
respectively (231, 232). Both receptors belong to the membrane-associated G-
protein-coupled receptor families, under the rhodopsin superfamily (231-236). The 
expression of these two receptors can also be found in the retina (237-239), brain 
(240, 241) and also many other tissues (122, 242-244). Whereas MT3 receptor 
belongs to the quinone reductase family and has only been identified in avians and 
rodents, but not in humans (234, 245). 
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The local effect of melatonin on cells through melatonin receptors is mediated by 
different pathways and secondary messengers depending on the cell type. For 
example, MTNRIA can activate protein kinase C-beta and down-regulate the activity 
of adenylate cyclase while MTNRIB can inhibit the guanylate cyclase pathway and 
stimulate protein kinase K (231, 232, 246). 
In human osteoblasts, the best recognized signaling pathway of melatonin receptor 
is the cAMP-dependent pathway. The activation of MTNRIA or MTNRIB by 
melatonin can inhibit adenylate cyclase activity (236), which results in the inhibition 
of forskolin-induced cyclic AMP formation, and leads to a decrease in activated 
protein kinase A (247) and subsequent downstream signaling. 
1.6.3 Melatonin's Role in the Skeletal System 
It is believed that melatonin can modulate growth in man and other mammals. In 
early studies, it was found that rats blinded or kept in constant darkness showed 
reduced tibial length and pituitary gland stores of growth hormone (GH) (248). The 
effects of blinding or constant darkness were abolished by pinealectomy. As 
melatonin is the main product of pineal gland and melatonin level peaks at night, the 
results suggested that melatonin has an inhibitory role in growth via its suppression 
on growth hormone secretion. Smythe et al. (249) further proved this theory by 
measuring GH level in rats with or without melatonin injection. Once again, rats with 
melatonin injection had a significantly lower level of growth hormone. 
Growth hormone is one of the main regulators of growth, particularly during the 
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rapid growth phase. It causes the increase in height during childhood and puberty by 
stimulating division and multiplication of chondrocytes and the production of insulin-
like growth factor 1, which has growth-stimulating effects on a variety of tissues. In 
fact, response of GH to melatonin is very likely to be age- and puberty-related (250). 
GH secretion and melatonin is negatively correlated in immature organisms (250). 
While in adults, melatonin enhances GH secretion (251). Therefore the effect of 
melatonin on growth through growth hormone is probably a negative one during 
childhood and prepuberty. 
Besides longitudinal bone growth, it is generally accepted that melatonin is 
associated with bone metabolism (121). The hypothesis stems from the occurrence 
of osteoporosis which begins at menopause (252), when melatonin level decreases 
dramatically (253). To investigate the relationship between melatonin and 
osteoporosis during menopause, Ladizesky et al. (254) evaluated the changes in 
urinary deoxypryrldinoline, calcium excretion, the levels of calcium and phosphorous 
in blood, and bone alkaline phosphatase in ovariectomized rats. BMD, BMC and BA 
•f the entire skeleton were also assessed after melatonin treatment. After 15 days, 
serum phosphorous and bone alkaline phosphatase increased significantly in the 
melatonin-treated groups. These results were confirmed by some other studies (255) 
and it is evident that melatonin can reduce bone resorption. Therefore, melatonin 
was proposed as a treatment for improving bone health in aged people with 
osteoporosis or osteopenia as age progression is closely related to the decreased 
level of melatonin (253, 256). 
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In-vitro studies of the direct effect of melatonin on osteoblasts are relatively fewer. 
(257-259). Roth et al. (258) reported that melatonin promoted cell differentiation 
and mineralization in two rodent osteoblastic cell lines (MC3T3-E1 and ROS 17/2.8) 
but has little or no effect on cell proliferation. The study by Nakade et al. (257) 
yielded opposite results showing that melatonin enhance proliferation but not 
differentiation in normal human osteoblasts. A more detailed study by Satomura et 
al. (259) may better explain the role of melatonin in osteoblast. The authors found 
that melatonin could stimulate proliferation, alkaline phosphatase activity and rate 
of mineralization in normal human osteoblasts in a dose-dependent manner. On the 
other hand, intraperitoneal injection of melatonin was able to increase the bone 
volume and newly formed cortical bone in the femurs of the mice. All the above 
studies suggested a positive effect of melatonin on bone cells. 
1.6.4 Melatonin-Deficient Scoliotic Animal Model 
As far as 1959, it was reported that scoliosis could be produced in chickens by 
pinealectomy (removal of the pineal gland) (260). After the operation, a spinal 
curvature similar to that in AIS was developed in these chickens. As the main 
secretory product of pineal gland is melatonin, the observation of the development 
of scoliosis after pinealectomy introduced the hypothesis that melatonin is 
associated with the occurrence of AIS. 
However, the rate of occurrence of scoliosis after pinealectomy varied greatly in 
different investigation (261-266). Scoliosis could not be induced in rats by 
pinealectomy alone (267). Researchers then postulated that the quadrupedal 
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movements of rats do not create the needed pressure on the spine as the bipedal 
movements of chickens and human to give scoliosis. To confirm this postulation, 
Machida et al. (268) created a few groups of rats: sham-operated bipedal, 
pinealectomized quadrupedal, pinealectomized bipedal, and pinealectomized with 
implanted melatonin pellets. It was discovered that only the pinealectomized 
bipedal rats developed scoliosis three months after the surgery. Moreover, 
treatment with melatonin pellet prevented scoliosis in 90% (9/10) of 
pinealectomized bipedal rats. 
However, when the experiment of pinealectomy was repeated in bipedal non-
human primates, the expected result of scoliosis could not be observed (269). 
Among the 18 pinealectomized rhesus monkeys, although 10 of them had a 
significant loss of melatonin secretion, none of them developed scoliosis in the 29 
months post-operative follow-up. Yet, this study is being criticized as the monkeys 
were not allowed to move freely or stand upright due to the limited space (270). 
Similar to the quadrupedal rats, the needed pressure of the spine to produce 
scoliosis was lacking. The findings suggested that both postural processes and 
melatonin deficiencies are crucial factors in scoliosis formation. 
A strain of mice with melatonin deficiency (C57BL/6J) may be a better tool to show 
the association of melatonin with development of scoliosis. C57BL/6J mice are born 
melatonin-deficient because its AA-NAT gene is knocked out during initial mating, 
which leads to reduced enzymatic rate of melatonin synthesis (271). AA-NAT gene is 
an important enzyme for the synthesis of melatonin from serotonin. Mice lacking 
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this enzyme exhibit a decreased melatonin level in plasma and pineal gland 
compared with other inbred mice. 
Machida et al. (263) successfully demonstrated the association of melatonin-
deficient and occurrence of scoliosis using this strain of mice. The occurrence and 
rate of development of scoliosis was assessed in both quadrupedal and surgically-
induced bipedal C57BLy6J mice. The effect of melatonin treatment by daily injection 
in reversing scoliosis development was also evaluated. The mice were sacrificed and 
their spines were examined by X-ray and 3D computed tomography (CT) 5 months 
post-op. It was found that nearly 100% of the melatonin-deficient bipedal mice 
(Figure 1.4) developed spinal deformity, against 25% of the quadrupedal model 
(Table 1.1). Melatonin treatment was able to prevent scoliosis development in both 
groups of mice. 
The team further studied the relationship between melatonin and scoliosis 
development by utilizing a strain of melatonin-proficient mice, C3H/HeJ. The 
forelimbs of the mice were removed and the rate of scoliosis occurrence was two-
fold less than the bipedal C57BL/6J mice. But when pinealectomy was performed in 
bipedal C3H/HeJ mice, the rate of occurrence increased to 70%. The results were in 
concordance with previous studies that spinal deformity would occur under the 
condition of melatonin deficiency and bipedal amputation. 
1.6.5 Melatonin and AIS 
Despite intense research, the etiology of AIS still remains unknown and is very likely 
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to be multifactorial. But with the evidences and findings mentioned above, it is 
suggested that melatonin may play an important role in the pathogenesis of scoliosis. 
1.6.5.1 Melatonin Level in AIS 
The occurrence of AlS-like scoliosis in pinealectomized chickens with reduced 
melatonin level led to the proposal of the theory of melatonin deficiency in AIS 
patients. (272-275). A study on serum melatonin level carried out by Machida et al. 
(276) found that there was significant difference when comparing progressive AIS 
patients with control and non-progressive AIS patients, but not between the normal 
control and non-progressive AIS patients. Their another study (277) also found that 
among the AIS girls with low serum melatonin level, melatonin treatment could 
reduce the rate of progression. However, other studies showed no difference in 
melatonin level in serum (130, 278) or urine (279, 280) between girls with AIS and 
normal control. Yet, these studies did not separate the AIS patients into progressive 
and non-progressive groups unlike the investigation by Machida et al. (276). The 
generalization of AIS patients as one group may not be able to show the lower 
melatonin level in some AIS patients. Therefore, the hypothesis of lower melatonin 
level in AIS patients and melatonin as a factor in the etiology of AIS is still 
controversial. 
1.6.5.2 Melatonin Receptor in AIS 
The effect of melatonin is mediated through a series of signaling pathways by 
melatonin receptors. Any dysfunction in the melatonin-signaling pathway may 
produce a melatonin-deficient-like condition. To investigate whether there is any 
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abnormality in the pathway, Moreau and Azeddine et al. (172, 281) assessed the 
ability of cAMP inhibition of osteoblasts under melatonin stimulation from 41 AIS 
patients and 17 control patients (Figure 1.5). Primary osteoblasts were cultured 
from bone biopsies obtained during spine surgeries. When melatonin was added to 
test its ability to block cAMP accumulation induced by forskolin, it was found that 
melatonin signaling was impaired in osteoblasts isolated from AIS patients albeit 
with different responses. The authors then classified the patients into three distinct 
groups, according to their responsiveness to melatonin. Moreover, this study 
suggested that the abnormalities in Gi protein function could cause melatonin 
signaling dysfunction. The group continued their study using cellular dielectric 
spectroscopy (CDS) (282) and discovered that the signaling dysfunction in AIS 
patients also occurred in their peripheral blood mononuclear cells (PBMCs). The 
results supported the theory of functional deficiency in Gi protein as the effects 
measured by CDS take place essentially through Gi protein. 
In line with the results above, Man et al. (283) discovered the abnormal response of 
proliferation and differentiation towards melatonin in osteoblasts from AIS patients, 
which can be divided into three groups as well. He also found the absence of 
melatonin receptors I B (MTNRIB) in some of the patients, which may explain the 
dysfunction of melatonin signaling pathway and abnormal response of proliferation. 
The mutation of genes might be a possible reason for any dysfunction in the 
melatonin signaling pathway. Qiu et al. (92) found a single nucleotide polymorphism 
(SNP) at the promoter region of melatonin receptor I B (MTNRIB) was associated 
31 
with the occurrence of AIS (92) but not with the curve severity. The authors 
suggested this may related to the expression of the receptor and hence lead to its 
functional deficiency. However, other research groups were not able to give positive 
results in different ethnic groups when repeating with the SNP found to be 
associated with AIS by Qiu et al. (100, 284-286). Despite the contradictory results of 
genetic studies, it is undoubtedly that melatonin play a key role in the pathogenesis 
of AIS based on all the evidence mentioned above. However, it is always Important to 
be reminded of the heterogeneity of the disease. Different etiologies, other than 
melatonin, are very likely to be involved in the incidence of scoliosis in different 
groups of AIS. Besides, whether the causative effect of melatonin in the etiology of 




Figure 1.1 Radiological Image of an AIS Patient with Right Thoracic Curve 
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Figure 1.3 Biosynthesis of Melatonin 
N-acetlytransferase (NAT) and hydroxyindole-O-methyletransferase (HIOMT) are key 
enzymes in the melatonin biosynthetic pathway. (Image adopted from Grivas TB et 
al. (119)) 
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Figure 1.4 Scoliosis Induced by Pinealectomy in a Bipedal Mouse 
(Image adopted from Machida et al. (263)) 
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Occurrence of Scoliosis 
No Melatonin Melatonin Treatment 
Treatment (8mg/kg) 
Bipedal C57BL/5J mice 97% (29 out of 30) 0% (0 out of 30) 
Quadrupedal C57BL/5J mice 25% (5 out of 20) 0% (0 out of 20) 
Table 1.1 Experimental Scoliosis in Melatonin-Deficient C57BL/6J Mice without 
Removal of Pineal Gland 
(Data reported and adopted from Machida et al. (263)) 
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Figure 1.5 The Effect of Melatonin on adenylyl cyclase activity in normal human 
and AIS osteoblasts. 
Results are represented by mean 土 SEM. (Graph adopted from Azeddine et al. (172)) 
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Chapter 2 Hypothesis and Objectives 
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2.1 Study Hypothesis 
Adolescent idiopathic scoliosis (AIS) is the commonest form of spinal deformity in 
adolescent girls. The current treatments are not satisfactory and have their own 
drawbacks and limitations as the etiology is not treated. It is therefore crucial to 
understand the etiopathogenesis of AIS in order to look for a better way of 
treatment or even preventive measures. Abnormal skeletal growth and metabolic 
dysfunction are two of the main hypotheses on the causes of AIS (134). It is believed 
that growth is closely related to the occurrence of AIS as adolescents experience 
rapid growth during puberty. AIS girls are generally taller and leaner. Previous 
studies (121-130) pointed out an abnormal growth and growth rate existed in AIS 
girls. Most of the reported studies were cross-sectional in nature and cannot 
provide more in depth understanding on the growth and growth pattern in AIS 
patients. Besides, the exact role of growth in the etiopathogenesis of AIS is still not 
dear; It has been reported that melatonin, a hormone secreted by the pineal gland, 
has significant effect on bone growth, such as proliferation and differentiation of 
osteoblasts (257) and bone mineralization (224). The effect of melatonin on growth 
hormone secretion (250) also suggested that melatonin may play an important role 
in skeletal growth. Apart from this, numerous evidences (134, 272-275) have 
indicated that melatonin is one of the key factors in the etiopathogenesis of AIS. 
Recent findings (281) suggested the existence of melatonin signaling pathway 
dysfunction in AIS girls, which may be due to the abnormal expression of melatonin. 
Taken all together, it is hypothesized that there is an abnormal growth pattern in AIS 
girls that is related to melatonin signaling dysfunction. 
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2.2 Objectives 
1. To study the anthropometric parameters, skeletal growth and growth pattern 
of AIS girls compared with normal female controls cross-sectionally and 
longitudinally. 
2. To establish an animal model of scoliosis induced by melatonin-deficiency with 
local breed chicken for the investigation of the associated abnormal growth 
pattern longitudinally. 
3. To investigate the melatonin signaling dysfunction in AIS girls by comparing the 
protein and mRNA expression of melatonin receptors between AIS patients and 
normal controls. 
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Chapter 3 Abnormal skeletal growth patterns in 
adolescent idiopathic scoliosis -A longitudinal 
study till skeletal maturity 
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3.1 Introduction 
Adolescent idiopathic scoliosis (AIS) occurs in children during their pubertal growth 
spurt. It is generally recognized that rapid growth is associated with the 
development and progression of the scoliotic curves (35, 159). Different cross-
sectional studies on skeletal growth of AIS girls have reported that AIS patients are 
taller and leaner than healthy controls (131, 287-296), indicating that growth in girls 
with AIS are different from normal. In both large cross-sectional studies by Cheung et 
a/. (131) and Goldberg et al. (297), it was shown that young AIS girls were taller 
initially but equalized during later phase of growth. It was then proposed that girls 
with AIS were running growth trajectories that were indistinguishable from normal 
peers who caught up by the end of growth. While other studies have shown that AIS 
girls were persistently taller than healthy subjects (131, 288, 290, 293, 298, 299). The 
inconsistency in the observations could result from the fact that most of the studies 
were cross-sectional in nature. 
Little et al. (168) observed in their longitudinal study that AIS girls had a higher peak 
height velocity. It was speculated that AIS girls had a different growth pattern from 
their normal healthy peers. In the classic study by Lonstein and Carlson (35), 
immature AIS patients was shown to had a greater probability of curve progression 
and the authors concluded that growth rate was important in the development of 
scoliosis. 
The above observations promoted further study on growth pattern of AIS girls which 
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may be related to the occurrence and progression of scoliosis. However, the cross-
sectional nature of most of the studies did not allow a comprehensive and in-depth 
understanding of the relationship. Therefore, the current study aimed to use both 
the cross-sectional and longitudinal anthropometric data and analyzed with an 
advanced linear mixed model to elucidate the growth pattern of AIS girls with 
different curve severities aged between 12 and 16. 
3.2 Methodology 
3.2.1 Recruitments of Subjects 
3.2.1.1 Patients with AIS 
704 Han Chinese girls with AIS, aged between 12 and 16 were recruited from a local 
scoliosis clinic at their first visit. Their status of scoliosis was diagnosed by clinical 
examination and standard standing scoliosis x-ray. Patients with diseases other than 
idiopathic scoliosis, or had scoliosis of congenital, neuromuscular, metabolic etiology, 
skeletal dysplasia and known endocrine and connective tissue abnormalities or have 
taken medications, were excluded from the study. Among the recruited AIS subjects, 
611 matched the inclusion criteria of Cobb angle > 2 ( R The maximum Cobb angle of 
each individual AIS girl at skeletal maturity or age older than 16 was used for the 
severity grouping. For surgical cases with Cobb angle > 40^, the largest Cobb angle 
before corrective spinal surgery was recorded as the curve severity. 
3.2.1.2 Normal Controls 
323 healthy age-matched Chinese girls without scoliosis were recruited from local 
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high schools. They were clinically examined, with forward bending test (300), by an 
experienced orthopaedics surgeon to confirm the absence of scoliosis. 27 healthy 
control girls found to have scoliosis (Cobb angle > 1 0 ” during the follow up were 
excluded from the analysis. 
3.2.1.3 Patients Consents 
The protocol had been approved by the Clinical Research Ethics Committee of the 
University. Informed consents were obtained and the details of the research were 
given to all the subjects and their parents before admitted into the study. 
3.2.2 Anthropometric Measurements 
Anthropometric parameters including body weight (BW), standing body height (BH) 
and arm span were measured using standard methods at each of their visits (301, 
302). The body weight was measured on an electronic balance (Soechnle, Germany) 
and the subjects were required to wear light garment, without shoes during the 
measurement. Accuracy was taken to the closest 0.1 kg. For the body height, 
subjects were measured without shoes by standing upright against a wall-mounted 
stadiometer, with their head positioned in the Frankfort horizontal plane and the 
heel against the stadiometer. Accuracy was taken to the closest 0.1 cm. For the arm 
span, subjects were asked to fully stretch their arm horizontally against a wall-
mounted tape for measurement. Accuracy was taken to the closest 0.1 cm. For AIS 
patients, corrected height was computed by Bjure's formula (log y = O.Ollx - 0.177; 
where y is the loss trunk height (cm) caused by the spinal deformity, and x is the 
Cobb angle of the major curve) (303). Body mass index (BMI) was calculated by 
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dividing weight (kg) by square of arm span (m^). Age of menarche was recorded. 
3.2.3 Data Analysis 
3.2.3.1 Cross-sectional Study 
AIS subjects were divided into 2 groups according to their Cobb angle. Patients with 
Cobb angle between 20 and 40 were referred as AIS20 and Cobb angle greater than 
40 as AIS40. Table 3.1 shows the distribution of different curve types among the AIS 
girls in 2 sub-groups. The differences in all anthropometric parameters (Standing 
body height, corrected body height, arm span, body weight and BMI) between AIS 
girls of different severities and control subjects were tested with one-way ANOVA 
using SPSS 16.0 (SPSS Inc., Chicago, IL). 
3.2.3.2 Longitudinal Study 
Among the recruited individuals, 194 AIS girls and 116 healthy girls agreed to 
participate in the longitudinal study for 2 years with 3 consecutive clinical and 
anthropometric assessments in a special clinic. The average follow-up assessment 
interval was 1.1±0.3 years. Among the recruited individuals, 194 AIS girls and 116 
healthy girls agreed to participate in the longitudinal study for 2 years with 3 
consecutive clinical and anthropometric assessments in a special clinic. The average 
follow-up assessment interval was 1.1±0.3 years. Linear mixed model was adopted 
to evaluate the growth pattern of AIS subgroups with respect to age and years since 
menarche. The linear mixed model was used to take account of irregular time 
intervals between measurements, imbalance data set and incomplete but 
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overlapping data set across the periods of interest (304-306). In the linear mixed 
model, random errors occurred with unequally spaced time points of measurements 
and declining correlation of errors with time is accommodated by the application of 
the spatial covariance structure to the model. After the application of this covariance 
structure to the data set with restricted/residual maximum likelihood (REML), an 
estimates of the covariance structure were substituted into the model which then 
used generalized least squares (GLS) method to assess curve severity and time 
effects on the change of different anthropometric parameters. SAS 8.0 (SAS 
Institutes Inc., Gary, NC) was used for analysis. Significance level of all the statistical 
evaluation was defined as p<0.05. 
3.3 Results 
3.3.1 Cross-sectional Study of Anthropometric Measurements 
At age 16 or older, after excluding those with Cobb angle smaller than 20 degrees, 
611 AIS girls were available for final analysis. 27 healthy control girls developed 
scoliosis during follow-up examinations and were excluded from all the analysis. 
Among the whole group, 194 AIS girls and 116 healthy girls were followed up 
longitudinally with a complete set of detailed anthropometric measurements. 
Table 3.2 and Table 3.3 show the results of all the 5 anthropometric parameters of 
AIS girls Vs control subjects at different age groups. No difference in body height and 
corrected height was found between AIS and control groups at different ages with 
the exception of a significantly shorter stature in AIS40 group at age 12. (Control and 
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AIS20). The corrected height of AIS40 group subsequently caught up and became 
significantly taller than the control group at age 14-16. For the AIS20 group, the 
corrected height was consistently taller than the control girls throughout age 12 to 
16. There was no statistical significance in corrected height between AIS20 and AIS40 
girls. 
For the arm span measurement (Table 3.2), both AIS20 and AIS40 groups were found 
to be significantly longer than the controls throughout age 12-16. Intergroup 
comparison showed that the AIS40 group started with a shorter arm span than the 
AIS20 group at age 12 but caught up and overtook subsequently at age 14-16. 
For the body weight comparison (Table 3.3), at age 12 the control group was heavier 
than both AIS20 and AIS40 girls. At age 13, AIS40 girls were significantly lighter than 
the control subjects. No further inter-group differences were observed between age 
14 and 16. For the BMI comparison, AIS20 and AIS40 had significantly lower BMI 
than controls across all ages except for age 15 (Table 3.3). 
3.3.2 Longitudinal Study of Anthropometric Measurements 
Table 3.4 and Table 3.5 summarize the longitudinal analysis of different 
anthropometric parameters with a linear mixed model. With the recent observations 
suggesting delayed onset of menarche in AIS girls (307), the age at menarche in the 
AIS girls with different severities was compared with healthy controls for the 
longitudinal follow-up cohort. AIS40 girls were found to have a significantly delayed 
onset of menarche than AIS20 girls (by 3.8 months) and healthy control (by 5.9 
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months). The AIS20 group also had a significantly delayed onset of menarche than 
the healthy control (by 2.0 months) (Table 3.6). 
To address the possible effect of skeletal maturity, and in addition to the analysis 
along with chronological age, the changes of different anthropometric parameters 
with year since menarche (YSM) were analyzed. 
3.3.2.1 Comparison Adjusted for Chronological Age 
There was no significant difference between AIS40 girls and healthy controls in body 
height and corrected body height. In the post-hoc analysis, AIS20 girls were 
significantly taller than the controls across the ages 12 to 16. For the arm span 
measurement, AIS40 group showed shorter arm span at age 12 which was followed 
by a significantly higher average growth rate than AIS20 girls and controls by 53% 
and 76% respectively (Table 3.4, Figure 3.1). For the body weight and body mass 
index (BMI), both AIS20 and AIS40 groups had significantly lower values than the 
controls. The rates of change in body weight and BMI between AIS girls and control 
were not significantly different (Table 3.5). 
3.3.2.2 Comparison Along Year Since Menarche (YSM) 
Similar to the analysis adjusted for chronological age above, no differences in body 
height and corrected body height were found between AIS40 and controls with 
respect to YSM (Table 3.4). However, in the post-hoc analysis, the corrected height 
of AIS20 girls were taller than that of controls. For the AIS40 group, both the rate of 
change of height (p=0.0239) and arm span (p二0.0011) were shown to be higher than 
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controls. Quantitatively, the growth rate of arm span in AIS40 exceeded that of the 
controls and AIS20 group by 71% and 30% respectively with a marginal statistical 
significance (p=0.07) (Table 3.4). Both the AIS20 and AIS40 groups had significantly 
lower body weight and BMI than the controls throughout the age groups (Table 3.5). 
To illustrate the difference between control and AIS girls with different severity, the 




Growth spurt during puberty is a key factor associated with the etiopathogenesis 
and curve progression in AIS patients (35, 159, 308). Many studies on height and 
weight of AIS girls have been conducted in the past and well summarized by Reinker 
(309). Despite inconsistencies between different reports, it is generally accepted that 
AIS subjects are taller and leaner. Studies (35, 159) showed that subjects who 
developed scoliosis were those with a higher peak height velocity and skeletally 
immature with greater remaining growth. This leads to the search for means to 
accurately measure peak height velocity. Sanders et al. (310) commented that the 
measurement of serial height and calculation of peak height velocity though simple 
in concept, are very difficult to carry out in practice. To circumvent these problems, 
attempts have been made to incorporate analysis of different maturity parameters 
(33, 145, 168, 311, 312) such as Risser sign, bone age and Tanner stage with the 
hope to provide a better estimation of the timing of the peak height velocity. The 
correlation of different parameters provides a reasonable assessment of maturity 
but is not totally reliable (33, 145). Therefore, in the present study, both cross-
sectional and longitudinal data were employed to compute the average growth rate 
of AIS girls aged between 12 and 16 in comparison with age-matched healthy control. 
In the cross-sectional analysis, severe AIS (AIS40) girls were found to have a shorter 
corrected height and arm span and lower body weight and BMI at age 12. The arm 
span and corrected height caught up subsequently and overtook the moderate AIS 
(AIS20) girls and control groups at age 14 to 16. The increase in corrected height and 
arm span of AIS40 girls was larger than that of AIS20 and controls. For the AIS20 girls 
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with moderate scoliosis, the increase in corrected height and arm span were also 
consistently higher than controls through age 12 to 16. The author speculated that 
severe AIS girls would have an abnormal skeletal growth rate when compared with 
moderate AIS girls and control. To prove this, the author showed that, in the 
longitudinal analysis with respect to both the chronological age and year since 
menarche (YSM), AIS40 girls was found to have significantly greater average growth 
rate in the arm span although they were found shorter than AIS20 girls and healthy 
controls in corrected body height and arm span at the beginning. This substantiated 
that severe AIS had an abnormal growth rate and indicated that the bone elongation 
mechanism was enhanced in severe AIS girls when compared with control healthy 
girls. For the AIS20 group, they had a consistently taller corrected height and longer 
arm span but their growth trajectory was similar to controls at ages 12 to 16 and 
after menarche. It is therefore speculated that moderate AIS girls might have the 
peak growth rate before age 12 or menarche and therefore they were taller and had 
a longer arm span during the periods examined in this study. Although both 
moderate and severe AIS girls had a significantly delayed menarche when compared 
with control girls in this study, the longitudinal analysis with respect to YSM still 
showed difference in growth trajectory of 2 sub-groups of AIS and normal controls in 
terms of arm span. With clear agreement with many previous studies (132,133,159, 
290) suggesting abnormal skeletal growth in AIS, all the present observations 
provide further evidence for the presence of abnormal skeletal growth and growth 
pattern in AIS at the per卜pubertal period. The severe scoliosis group AIS40 was also 
found to have different growth pattern from that of moderate group of AIS20. 
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The findings is in line with the hypotheses that certain hormonal metabolic 
dysfunction in severe AIS girls might affect the control and modulation of the 
systemic skeletal growth and sexual maturation in the peri-pubertal period and 
contribute to the etiopathogenesis of AIS (184, 309). Similar observations were also 
suggested that happened in the moderate AIS girls in different patterns. The 
magnitude of the growth rate is likely to affect the severity and progression of 
scoliotic deformity during ages 12 to 16 and thus gives rise to two subgroups of 
moderate and severe AIS. In this study, the body weight and BMI of the AIS girls 
were found to be consistently lower than the healthy controls and the average rate 
of change of these parameters were similar. With this observation, it is unlikely that 
the enhanced skeletal growth in severe AIS girls is a catch-up growth because the 
characteristics of catch-up growth in adolescence is the concurrent increase of 
height and weight back to the normal range (313). 
In addition to regular anthropometric measurements (131, 147), the current study 
used the growth pattern and growth rate of arm span -- a more reproducible and 
reliable clinical anthropometric parameter than the formulae based on corrected 
body height for documentation. Significantly high linear correlation between arm 
span and standing height in healthy children and adolescents has been shown (r^ = 
0.99) (301, 314). 
In summary, the present study provided objective information on the abnormal 
growth pattern and delayed sexual maturation in AIS with confirmed curve severity 
which could be related to abnormal modulation or regulatory mechanism of 
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systemic skeletal growth and maturation that could play significant role in the 
etiopathogenesis of AIS. The change of growth regulatory mechanism in AIS would 
require further studies such as the underlying molecular genetic characteristics and 
environmental influence (315). The clinical measurement of arm span growth could 
be an important clinical parameter in helping to predict the development of severe 
scoliosis in AIS and warranted further prospective longitudinal investigation. 
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Table 3.1 Curve type and their average Cobb angle of AIS girls with different 
severity. 
AIS20 AIS40 
Major Thoracic 38.1% 44.1% 
Double Thoracic 6.6% 5.6% 
Double Major 17.2% 20.3% 
Thoracolumbar 25.0% 15.4% 
Lumber 7.5% 
Triple 5.6% TnJo ” 
Mean Cobb angle 29.0±5.4 52.8±10.2 
AIS20: AIS girls with Cobb angle between 2 0 � a n d 40。； AIS40: AIS girls with Cobb 
angle >40" 
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Table 3.2 Cross-sectional Comparison of body height (BH), corrected body height 
according to Bjure's formula (BHcor) and arm span between control subjects and 
AIS girls with different severity and different age groups 
A ^ | l 2 [l3 [l4 | l5 We 
Mean±S.D. (n) MeaniS.D. (n) MeaniS.D. (n) MeaniS.D.~(n) M e a n i S . D . ( r i T 
BH(cm) 
Control|l53.18±5.49 (59)[l54.76±5.53 (97) |l55.94±4.40 (61) |l57.86±5.52 (45)|l57.85±5.09 (34) 
AIS20 152.73±6.33 (87) 155.63±5.99 (123) 157.53±5.49 (129) 160.06±6.43 (72) 159.73±6.52 (38) 
AIS40 148.43±7.90 (39) 154.32±5.75 (40) 156.73±6.62 (40) 159.75±6.00 (27) 159.87±5.58 (16) 
P-vaiue 0.001*(a) 0.352 0.167 0.153 0.326 
BHcor (cm) 
Control|l53.18±5.49 (59)|l54.76±5.53 (97) |l55.94±4.40 (61) |l57.86±5.52 (45)|l57.85±5.09 (34) 
AIS20 153.89±6.32 (87) 156.91±6.00 (123) 158.80±5.49 (129) 161.31±6.39 (72) 160.92±6.51 (38) 
AIS40 149.95±7.83 (39) 156.04±5.78 (40) 158.62土5.72 40) 161.26±6.10 (27) 161.48±5.65 (16) 
P-value 0.006*(a) 0.025*(b) 0.002*(c) 0.008*(c) 0.044*(c) 
Arm span (cm) 
Control|l52.48±7.01 (59)|l53.30±6.32 (97) |l54_72土5.83 (61) |l56.32±5.73 (45)|l55.74±5.84 (34) 
AIS20 153.44±7.26 (87) 156.13±7.29 (123) 158.05±6.57 (129) 160.05±6.75 (72) 160.48±6.60 (38) 
AIS40 149.40±8.77 (37) 154.92±5.67 (40) 159.81±7.26 (39) 162.04±8.09 (27) 160.25±6.60 (16) 
p-value 0.025*(d) 0.009*(b) <0.001*(c) 0.001*{c) 0.005*(c) 
(a) Post Host Test (LSD): AIS40 vs. Control and AIS20, p < 0.05 
(b) Post Host Test (LSD): AIS20 vs. Control, p < 0.05 
(c) Post Host Test (LSD): Control vs. AIS20 and AIS40, p < 0.05 
(d) Post Host Test (LSD): AIS40 vs. AIS20, p < 0.05 
AIS20: AIS girls with Cobb angle between 20° and 40。； AIS40: AIS girls with Cobb 
angle > 4 ( r 
* p<0.05 (one-way AN OVA) 
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Table 3.3 Cross-sectional comparison of body weight (BW) and body mass index 
(BMI) between control subjects and AIS girls with different severity and different 
age groups 
Age 12 fl3 Il4 fl5 [l6 
MeaniS.D. (n) Mean土S.D. (n) Mean土S.D. (n) M e a n ± S . D . ( n ) Mean土S.D. (n) 
BW (kg) 
Control 44.0119.00 (59) |43.88±6.94 (97) |44.82±7.19 (61) |46.42±8.57(45)丨48.17±6.51 (34) 
AIS20 40.38±6.44 (87) 42.37±7.00 (123) 44.11±7.50 (129) 45.62±7.47 (72) 46.54±6.11 (38) 
AIS40 37.77±8.72 (39) 40.02±6.75 (40) 43.56±6.44 (39) 46.07±7.03 (27) 46.95±7.82 (16) 
P-value <0.001(b) 0.012*(c) 0.683 0.862 0.570 
2 
BMI (kg/sq. m) 
Control |18.68±3.21 (59) |l8.29士2.56 (97) |l8.43士2.84 (61) | l8 .61±3.13(45) |l9.35±2.52 (34) 
AIS20 17.00±2.24 (87) 17.15±2.18 (123) 17.45士2.44 (129) 17.52±2.54 (72) 17.95±1.97 (38) 
AIS40 16.71±3.19 (39) 16.41±2.45 (40) 17.21±2.12 (39) 17.68±2.20 (27) 17.98±2.64 (16) 
P-value <0.001(b) <0.001(b) 0.021*(b) 0.095 o.029*(a) 
(a) Post Host Test (LSD): AIS20 vs. Control, p < 0.05 
(b) Post Host Test (LSD): Control vs. AIS20 and AIS40, p < 0.05 
(c) Post Host Test (LSD): AIS40 vs. Control, p < 0.05 
AIS20: AIS girls with Cobb angle between 2 0 � a n d 40"; AIS40: AIS girls with Cobb 
angle >40° 
* p<0.05 (one-way AN OVA) 
57 
Table 3.4 Longitudinal analysis of the change of different anthropometric 
parameters between AIS girls and health controls (age 12-16) with respect to age 
and years since menarche. 
Age YSM 
Body Height Control AIS20 AIS40 Control AIS20 AIS40 
Estimate Intercept(cm) 134.46 134.82 133.48 154.12 154.70 153.33 
Std. Error 0.85 0.82 1.39 0.92 0.88 0.72 
p-value (a) 0.2514 0.1053 0.3909 0.1198 
Average growth rate between 
age 12-16 (cm/yr) 1.5858 1.5858 1.5858 1.3804 1.4822 1.8849 
Std Error 0.0866 0.0866 0.0866 0.2228 0.2229 0.1802 
P-value (a) <.0001(c) 0.0239* 0.0713 
Corrected Body Height Control AIS20 AIS40 Control AIS20 AIS40 
136.36( “ 
Estimate Intercept (cm) 134.83 b) 135.47 154.12 155.94(b) 155.07 
Std. Error 0.85 0.83 1.39 0.93 0.89 0.72 
P-value (a) 0.4521 0.2809 0.3065 0.3278 
Average growth rate between 
age 12-16 (cm/yr) 1.5596 1.5596 1.5596 1.3807 1.4516 1.7901 
Std Error 0.0866 0.0866 0.0866 0.2236 0.2237 0.1809 
P-value (a) <.0001*(c) 0.0676 0.1308 
Arm Span Control AIS20 AIS40 Control AIS20 AIS40 
Estimate Intercept (cm) 137.91 137.52 126.34 153.20 155.11(b)~154.45 
Std. Error 3.83 3.83 3.13 1.14 1.09 0.89 
0.0036 
P-value (a) 0.0026* * 0.2708 0.5434 
Average growth rate between 
age 12-16 (cm/yr) 1.241 1.428 2.1816 1.1351 1.4957 1.9435 
Std. Error 0.2624 0.2633 0.2155 0.2459 0.2473 0.1996 
0.0044 
P-value (a) 0.0004* * 0.0011* 0.0706 
(a) p-values represent the comparison between AIS40 and Control or AIS40 and 
AIS20 
(b) Statistically significant difference (p<0.05) between AIS20 and Control in post-hoc 
test 
(c) The p-value indicates that age and YSM was a statistically significant independent 
parameter in the model but no group interaction in age or YSM. 
AIS20: AIS girls with Cobb angle between 20° and 40"; AIS40: AIS girls with Cobb 
a n g l e � 4 0 ° * p < 0.05 
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Table 3.5 Longitudinal analysis of body weight (BW) and body mass index (BMI) 
between AIS girls and health controls (age 12-16) with adjustment for age and year 
since menarche. 
Adjusted for Age Adjusted for YSM 
Body Weight Control AIS20 AIS40 Control AIS20 AIS40 
Estimate Intercept 
(kg) 20.61 18.00 16.57 42.82 40.71 39.90 
Std. Error 1.11 1.08 1.80 1.03 1.00 0.83 
P-value (a) 0.0003* 0.1842(b) 0.0051 0.4193(b) 
Average rate of 
change between 
age 12-16 (kg/yr) 1.8408 1.8408 1.8408 1.9489 1.9489 1.9489 
Std. Error 0.1117 0.1117 0.1117 0.1049 0.1049 0.1049 
p-value (a) <0.0001(c) <0.0001(c) 
_BMJ Control AIS20 AIS40 Control AIS20 AIS40 
Estimate Intercept 
(kg) 13.29 11.62(b) 11.18 18.36 16.81(b) 16.53 
Std. Error 0.39 0.38 0.68 0.37 0.36 0.30 
P-value <0.0001* 0.2539 <0.0001 0.4338 
Average rate of 
change between 
age 12-16 (kg/yr) 0.4257 0.4257 0.4257 0.4921 0.4921 0.4921 
Std. Error 0.0429 0.0429 0.0429 0.0406 0.0406 0.0406 
P-value (a) <0.0001(c) <0.0001(c) 
(a) p-values represent the comparison between AIS40 and Control or AIS40 and 
AIS20 
(b) Statistically significant difference (p<0.05) between AIS20 and Control in post-hoc 
test 
(c) The p-value indicates that age and YSM was a statistically significant independent 
parameter in the model no group interaction in age or YSM. 
AIS20: AIS girls with Cobb angle between 20° and 40°; AIS40: AIS girls with Cobb 
angle >40° 
* p < 0.05 
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Table 3.6 Comparison of Age at Menarche between AIS girls and healthy control 
subjects including in the longitudinal follow-up study. 
Control AIS20 AIS40 
n 116 " m p-value 
Age at Menarche 12.14±1.1 12.31±1.27(a) 12.63±1.13 (b) 0.024* 
* p<0.05 (One-way ANOVA) 
(a) p<0.05 (Post-hoc Bonferroni test) when AIS20 and AIS40 were compared 
(b) p<0.05 (Post-hoc Bonferroni test) when Control and AIS40 were compared 
AIS20: AIS girls with Cobb angle between 20° and 40。； AIS40: AIS girls with Cobb 
angle >40° 
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Figure 3.1 Representative chart of the growth rate of arm span of AIS girls and 
healthy controls between age 12 and 16 based on the derived model in Table 3.4 
The arm span of severe AIS girls was shorter than normal controls and moderate AIS 
girls at age 12 but surpassed the other two groups at age 15, indicated a faster 
growth rate of severe AIS girls. Moderate AIS girls had a consistently longer arm span. 
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Figure 3.2 Representative chart of the growth rate of arm span of AIS girls and 
healthy controls adjusted by year since menarche based on the derived model in 
Table 3.4 
The severe AIS girls had a faster growth rate than normal control and moderate AIS 
even after the adjustment by year since menarche while moderate AIS girls had a 
consistently longer arm span than control. 
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Chapter 4 Establishment of a Melatonin-Deficient 




In the previous chapter, the growth pattern of AIS girls after the onset of scoliosis 
was studied. It was shown that an abnormal growth pattern occurred in AIS patients. 
They have a taller stature, leaner body build, longer arm span and their growth 
pattern is different from that of healthy girls. The growth rate of AIS patients, 
particularly the severe ones, is faster than healthy controls. It was indicated that 
different growth patterns in AIS girls could lead to different curve severities. 
However, it is not clear whether the difference in growth pattern would lead to the 
development of scoliosis. To achieve this, we could longitudinally follow a large 
cohort of adolescents with detailed measurements of skeletal growth, analyze their 
growth patterns and its correlation with the occurrence of scoliosis. The required 
volume of subjects would be very large as the prevalence of AIS is about 3.6% in girls 
and 1.3% in boys (16) in the general population, which seems to be impractical for 
this study. Thus, it is necessary to use an alternative method to investigate the 
possible role of abnormal growth pattern in the etiopathogenesis of AIS. In the 
present study, a scoliotic animal model was adopted to study any abnormal growth 
pattern in the animal before the onset of scoliosis. 
The first scoliotic animal model was developed by Thillard et al. (260) in 1959. He 
reported that pinealectomy could produce scoliosis in chickens and the curvature 
was similar to that in AIS patients. Thereafter, scoliotic models were being 
developed in other animals such as rats, monkey and salmon (131, 262, 268). In a 
study of scoliotic rat model (268), Machida et al. found that, among all 
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pinealectomized rats, only bipedal rats, but not quadrupedal rats could develop 
scoliosis three months after the surgery. Cheung et al. (316) tried to develop a 
scoliosis model in non-human primates by pinealectomy. However, scoliosis was not 
observed in any of the monkeys twenty-nine months post-op even though the 
surgery was successful with a significant loss in melatonin secretion in 
pinealectomized monkeys. Yet, the design of this study was criticized as the monkeys 
were housed in a limited area which did not allow free movement or even standing 
upright (270). These findings suggested that postural process is an important factor 
to induce scoliosis. 
By now, the most successful scoliotic animal model was found to be chicken (274) 
and it is adopted in most of the research on the etiopathogenesis of AIS (272, 274, 
317-322). Chickens are bipedal by nature, which resembles the biomechanics of 
human spine (323). Besides, scoliosis usually occurs in chickens within 2-3 weeks 
post-pinealectomy (274), which is much faster than rats (3 months) (268) or rhesus 
monkeys (20+ months) (316). The procedures of pinealectomy in chickens are also 
relatively simple when compared to the operation on rat and monkey as the pineal 
gland of chickens lies just beneath the dura mater at the top of the skull and 
between two cerebral hemispheres (322). The simplicity of the operation reduces 
the probability of damaging the brain and other associated complications. 
The relationship between growth and scoliosis development was studied in a 
scoliotic chicken model firstly by Beuerlein (317) where he tried to compare the 
growth pattern and the time of occurrence of scoliosis between two breeds of 
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chickens with different growth rate, namely the White Leghorn and Mountain 
Hubbard chickens, after pinealectomy. It was found that Mountain Hubbard chicken, 
the one with faster growth rate in terms of weight, developed scoliosis earlier than 
its counterpart. The author hence concluded that growth was an important factor in 
scoliosis development. However no difference in growth pattern between the 
pinealectomized and sham chickens within the same breed, nor the rate of 
occurrence of scoliosis between the two breeds was found. 
Besides growth, other phenotypic abnormalities in AIS patients such as lower bone 
mineral density (138, 142, 324), could be observed in a pinealectomy-induced-
scoliosis chicken model (Hydro Broiler chicken) (265). The authors commented that 
the results were in concordance with other studies (224, 257, 325) that melatonin 
had a direct stimulating effect on osteoblast proliferation (257) and. bone 
mineralization and bone formation (224, 325). Therefore, removal of the pineal 
gland, which leads to a significant loss of melatonin, could lead to low bone mass 
together with scoliosis. 
In Chapter 3, the anthropometric study showed that AIS girls had an abnormal 
growth pattern between age 12 and 16. It was shown that severe AIS girls had higher 
growth rate during this period. It is speculated that the growth rate or growth 
pattern plays an important role in development of scoliosis. Hence, it was 
hypothesized that the growth pattern of the scoliosis chicken model was altered 
which led to the initiation of scoliosis. However, the previous studies (268, 272, 317) 
were insufficient to identify any abnormality in skeletal growth in scoliotic animals 
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and its relationship with occurrence of scoliosis. Therefore, in the present study, a 
local scoliotic chicken model (Kamei chicken) was established to monitor the skeletal 
growth pattern in detail between pinealectomized and sham-operated chickens. Any 
altered growth pattern was correlated with the occurrence of scoliosis. The outcome 
of the study could help to explain the clinical observation of abnormal growth of AIS 
patients and its relationship with scoliosis. 
4.2 Methodology 
4.2.1 Animals 
Twenty unisex Kamei chickens (Gallus gallus domesticus) obtained from local farm 
were used in this study. They were separated into two groups: Pinealectomized 
group (n=12) and Sham-operated group (n二8). All of them were immediately 
introduced to a 12:12 hour dark-light cycle after hatching and this cycle was 
maintained until the end of the experiment. They were kept in a temperature- and 
humidity-controlled room and fed with water and chicken diet ad libitum. The 
chickens were kept for 5 weeks after the operation. The experimental protocols had 
been approved by University Animal Research Ethic Committee (Ref: 10/098/MIS). 
4.2.2 Materials and Reagents 
4% Buffered Formalin 
16.25 g of Na2HP04(Merck & Co., Darmstadt, Germany) and 10 g of NaHzPO-(Merck 
& Co? Darmstadt, Germany) were dissolved in I L MilliQ water. 250 ml of 37% 
formaldehyde solution (RCI Labscan, Bangkok, Thailand) was added and the final 
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volume was made up to 2.5L and pH was adjusted to 7.4. The solution was stored at 
room temperature. 
Phosphate Buffered Saline (PBS) 
1.44 g Na2HP04, 0.24 g KH2PO4, 8.0 g NaCI and 0.2 g KCI all from Merck & Co., 
Darmstadt； Germany were dissolved in 900 ml distilled water. The pH was adjusted 
to 7.4 and the final volume was made up to 1000 ml with distilled water. The 
solution was sterilized by autoclaving and stored at 4°C. 
4.2.3 Pinealectomy 
Chickens at 3 days old were first anesthetized by inhaling isoflurane (Halocarbon, 
South Carolina, USA) mixed with oxygen. They were kept under anesthesia 
throughout the whole operation (Figure 4.1A). The head was sterilized after shaving. 
A small cut was made to the skin above the superior sagittal sinus and was extended 
to the confluence of sinuses until the skull was exposed (Figure 4.IB). A 3mm 
incision was made perpendicularly to the superior sagittal sinus using a surgical 
blade (Figure 4.1C). At both ends of the incision, cuts were made along the sagittal 
sinus using a dissecting scissors and extended across the transverse sinuses to make 
a 门 shape (Figure 4.1C). The cut allowed a flap of soft bone to be pulled back as the 
skull bone was still very soft. The pineal gland was attached to the skull bone and 
could be pulled out with the bony flap (Figure 4.1D). To confirm that the surgery 
could completely remove the pineal gland, the bone flap was removed together with 
the soft tissue for histology in three chickens which was sacrificed immediately. For 
other chickens, the pineal gland was carefully removed from the bone flap with 
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forceps. The flap of skull was hinged back gently and the soft tissue wound was 
closed with non-absorbable 5-0 suture. After the process, anesthetic was removed 
and the chicken was kept under 38�C until it was completely recovered and began to 
feed. For the sham group, only 3 cuts of a n shape on the skull were made without 
pulling up the skull flap and removal of the pineal gland. 
4.2.4 Confirmation of Pineal Gland Removal 
The removed tissue from the bone flap (and the bone flap together with the soft 
tissue in one of the sacrificed chicken) from the operation was rinsed briefly with 
phsophate buffered saline (PBS) followed by fixation with 4% buffered formalin for 1 
hour and placed in 70% alcohol afterwards. They were dehydrated in graded alcohol 
and processed into paraffin wax with an automated tissue processor (Shandon, 
Pathcentre, Thermo). The pineal gland in paraffin was sectioned with 5|im in 
thickness. The sections were stained with hematoxylin and eosin and examined 
under a light microscope to confirm that the removed tissue was the pineal gland. 
4.2.5 Development of Scoliosis 
The development of scoliosis of chickens was monitored longitudinally by plain 
radiographic imaging twice a week (Day 3 and 6 of the week), starting from day 2 
after surgery, until day 35 post-op. Under general anesthesia with isoflurane the 
chickens were radiographed in a supine position (Figure 4.2A). The position of the 
head was fixed and its body was slightly tilted to ensure the neck and legs were fully 
extended. The body was positioned carefully to ensure the sternum was right above 
the vertebral column and the pelvis was leveled. These maneuvers were employed 
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to ensure the presence of scoliosis was not due to positioning problem. All the 
radiographs were taken with aluminum step wedges for calibration of image 
intensity. The presence of scoliosis was determined from the radiograph (Figure 
4.2A). Cobb angle greater than 10° was defined as scoliosis. The measurement of 
Cobb angle followed Cobb's method (1) with the image analysis software ImageJ 
(v.1.43, NIH, USA). The rate of change of Cobb angle was determined. The spine was 
obtained after sacrifice and subjected to Micro computed Tomography (MicroCT) 
scanning for construction of 3D images of the spine and the confirmation of any 
deformation. 
4.2.6 Measurement of Long Bone Growth 
Another radiograph was taken with the chicken lying on its right side, its right wing 
and leg lied flat and its position fixed (Figure 4.2B). All the radiographs were taken 
with aluminum step wedges for image intensity and length calibration. The length of 
tibia of the right side was measured on the X-ray image using ImageJ (v.1.43, NIH, 
USA). Measurements were made to the closest 0.1mm. Length of tibia, instead total 
body length, was used to determine the longitudinal skeletal growth of the chickens. 
This is because body length could be greatly affected by natural curvature or 
curvature due to scoliosis of the spine. It is also difficult to have a consistent 
positioning of the whole body during radiograph taking, whereas the measurement 
of the length of tibia is relatively more reproducible. Growth rate was expressed in 
percentage change in length of tibia per day, and was correlated with the initial 
Cobb angle and the rate of change of Cobb angle. Only chickens sacrificed after week 
2 post-op were included in this longitudinal analysis. 
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4.2.7 Measurement of Weight 
Weight of each chicken was measured twice a week on an electronic balance before 
taking radiograph. Only chickens sacrificed after week 2 post-op were included in 
this longitudinal analysis. Measurements were made to the closest 0.5 g. 
4.2.8 Measurement of Bone Mineral Density (BMD) 
4.2.8.1 Micro-Computed Tomography (MicroCT) 
In order to study the growth of chickens, they were sacrificed for femur midshaft 
BMD assessment at different time points. The time points for sacrifice are shown in 
Table 4.1. The right femurs of chickens were harvested carefully to prevent any 
artifacts. The specimens were fixed with 4% buffered formalin for one day and 
stored in 70% alcohol. Volumetric BMD of the midshaft of right femur was measured 
by micro computed tomography (\xCJ) (MicroCT40, Scanco Medical, Basselsdorf, 
Switzerland). The length of femur was measured first and a projectional scout view 
was performed to define the region of interest (ROI), which was the midshaft of the 
femur. The voxel size of scans was 20 [im and there was no gap between individual 
slices of the scans. 
4.2.8.2 Image Processing and Evaluation of BMD 
After the two-dimensional images from the microCT scan were obtained, 110 slices 
of the midshaft of femur were reconstructed to 3-dimensional (3D) images for 
histomorphometric analysis. The region of interest was defined with build-in 
contouring function of the image processing software. The BMD value was 
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computed using the in-built 3D histomorphometric analysis program, with the gauss 
Sigma value of 1.0, gauss support value of 1, and threshold of 183. 
4.2.9 Data Analysis 
4.2.9.1 Measurements of Long Bone Growth and Weight 
Only chickens kept for more than 16 day post-op (i.e. 7 Pinealectomized and 6 Sham 
chickens) (Table 4.1) were included for the longitudinal analysis. The tibia length and 
weight were compared between groups using a multivariate regression model to 
determine whether there were any differences in magnitude as well as the trend. 
For the growth pattern, repeated-measure two-way ANOVA and Independent 
Student's t-test were performed on Days 6, 9 and 13 post-op, when the growth 
pattern was shown to be different between groups by observation. All data were 
expressed as mean 土 S.D and SPSS 16.0 (SPSS Inc., Chicago, IL) was used for all the 
analysis above. Significance level of all statistical evaluations was defined as p<0.05. 
4.2.9.2 Bone Mineral Density 
Bone mineral density was derived from the measured bone mineral content (mg HA) 
divided by the detected bone volume (cm^) using the in-built software. Multivariate 
regression analysis was done for cross-sectional study. SPSS 16.0 (SPSS Inc., Chicago, 




4.3.1 Confirmation of Pineal Gland Removal 
The soft tissue removed from the surgery of each chicken was fixed and sectioned 
for histology and examined under a microscope to confirm the complete removal of 
pineal gland. Figure 4.3 shows a representative pineal gland at different 
magnification stained with hematoxylin and eosin. Figure 4.3A shows that the soft 
tissue attached to the bone flap being the pineal gland, thus confirming the 
complete removal of the pineal gland with the surgical procedures. On Figure 4.3B, 
the typical morphological characteristics of pineal, such as follicular lumen (L) and 
connective-vascular partition (CVP) could be clearly observed. And as indicated on 
Figure 4.3C, there was a clear differentiation of the follicular (F) and parafollicular 
(PF) zones around the lumens. The morphology was comparable with published 
histology (326, 327). 
4.3.2 Occurrence of Scoliosis 
Out of the twenty chickens studied in the experiment, twelve were assigned to the 
pinealectomized group and eight to the sham group. Eight pinealectomized chickens 
and four sham chickens were sacrificed during the experiment for the assessment of 
BMD at different time points before the end of the 5-week experiment. Four 
chickens from each group were followed for 5 weeks post-op. All the 
pinealectomized chickens developed scoliosis (n=7) within 13 days post-op except 
one at day 23 post-op. Figure 4.4 shows a pinealectomized chicken with scoliosis at 
week 4 after the surgery and Figure 4.5 shows the spine of a scoliotic chicken with 
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deformation at T5-T7 obtained after sacrifice. None of the chickens from the sham 
group developed scoliosis (n二6) throughout the whole experiment (Figure 4.6). Table 
4.2 shows the time point of occurrence of scoliosis for the two groups and Table 4.3 
shows the Cobb angle for each pinealectomized chicken along their growth. The 
initial Cobb angle was greater than 10°. The final Cobb angle increased with the 
follow-up time. Except one chicken, all scoliotic chickens developed a curve of more 
than 30 degrees. 
4.3.3 Measurements of Long Bone and Weight 
Figure 4.7 shows the average growth rate of the chickens, denoted by the 
percentage change of length of tibia per day. Both groups started with a similar 
growth rate at Day 2 post-op followed by an increase at Day 6 post-op. The growth 
rate of sham chickens then decreased gradually afterwards. For all the 
pinealectomized chicken, there was a sudden drop of growth rate after Day 6 post-
op and a quick increase after Day 9 post-op. The growth rate then dropped gradually 
afterwards. This kind of M-shape-like growth could not be observed in any of sham 
chickens. The growth rate at the first peak, second peak and trough of the M-shape-
like growth of pinealectomized chicken was correlated with the initial and the rate of 
change of Cobb angle. No significant correlation was found (Figure 4.8). Table 4.4 
shows the time of occurrence of the M-shape-like growth of chickens. 
Among all the pinealectomized chickens, only one chicken showed a growth rate 
drop at Day 13 and then increased on Day 16 after operation. With the delay of the 
occurrence of the M-shape-like growth, the scoliosis also occurred later on Day 23 
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post-op (Figure 4.9). Due to the possible variation between individual chickens, this 
chicken with a distinct delay of occurrence of a M-shape-like-growth was not 
included in the between group analysis and used as a case study in the discussion. 
Using independent t-test, the growth rate at Day 9 and Day 13 post-op was found to 
be significant when compared between pinealectomized group and sham group with 
the p-value = 0.008 and 0.023, respectively (Table 4.5). Two-way ANOVA (Table 4.6) 
shows that both the time and group had an effect on the pattern of growth rate in a 
quadratic manner between Day 6 and 13 with statistical significance (p=0.002). 
Six pinealectomized (excluding the chicken with a delayed M-shape-like-growth) and 
six sham chickens kept for more than two weeks were included in the longitudinal 
analysis of tibia length (Figure 4.10) and weight (Figure 4.11). All parameters 
increased in a relatively steady rate for both groups and their charts were 
overlapping. No significant difference in tibia length and body weight was found 
between pinealectomized and sham groups. 
4.3.4 Measurement of Bone Mineral Density 
Twelve pinealectomized and eight sham chickens were subjected to microCT analysis 
of BMD at different time points after their sacrifices for a cross-sectional study. The 
BMD for both groups increased linearly as the chickens grew during the 5-week 
experiment and the trend was similar between two groups (Figure 4.12). 
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4.4 Discussion 
To the best of the authors' knowledge, this is the first study to demonstrate the 
abnormality in growth rate pattern exclusively in scoliotic chicken prior to the 
development of scoliosis. The change in growth rate pattern after pinealectomy was 
likely to be directly related to the occurrence of scoliosis in chickens. The growth 
rate of tibia of chickens was used to represent the system bone elongation. The 
growth rate of pinealectomized chickens showed a sudden drop on Day 9 post-op 
followed by an increase on Day 13 post-op with two peaks. This kind of M-shape-
like-growth (Figure 4.7) was not observed in any of the sham chickens and scoliosis 
occurred immediately right after this eccentric growth. The growth rates at Day 9 
(Post-up) (trough of growth rate of pinealectomized chickens) and Day 13 post-op 
(re-bounce of growth rate of pinealectomized chickens) were significantly different, 
indicating that the growth of scoliotic chickens was indeed affected. 
For anthropometric measurements, the length of tibia and body weight were 
measured. While differences in height and weight between AIS patients and normal 
control was not observed, it was not detected in this chicken model when comparing 
the length of tibia and weight between scoliotic and control chickens. The 
anthropometry of scoliotic chicken model had been studied previously (272). No 
difference in weight and length of spine between the pinealectomized and sham 
group was reported. The difference in growth rate pattern was not reflected in the 
growth pattern of long bone. This may be due to the small difference in the length 
and limited sample size as there were only six pinealectomized chicken and six sham 
chickens. 
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Previously, Beuerlein (317) demonstrated that growth was closely related to scoliosis 
development with scoliotic chicken models using two breeds of chickens with 
different growth rate. The breed with faster growth rate was found to develop 
scoliosis earlier. However, the author was not able to detect any difference in 
growth rate between the scoliotic (pinealectomized) and non-scoliotic (sham) 
chickens as observed in this study. In Beuerlein's experiment, the growth of chickens 
was studied in terms of weight and length of spine. The weight could not reflect 
skeletal growth whereas the length of spine could be easily affected by the three 
dimensional curvature of spine. In the present study, tibia length was measured 
which may better represent the skeletal growth. Besides, the parameters were 
measured twice per week in contrast to once per week in Beuerlein's study. The 
difference in growth rate between pinealectomized and sham chickens was actually 
quite subtle and could only be observed within a one-week time frame. The different 
methods, measurement parameters and time points adopted may explain the 
seemingly contradictory results of the two studies. 
Nevertheless, the occurrence and progression of scoliosis are well accepted to be 
closely related to skeletal growth in girls with AIS during their peri-pubertal period 
(146). In a study by Little et al. (168), AIS patients were shown to have a higher peak 
height velocity. The results from the cross-sectional study by Cheung et al. (131) also 
suggested that girls with AIS are running different growth trajectories. However, as 
the AIS patients were recruited after development of scoliosis, their growth before 
the onset of scoliosis was not monitored and still remained obscure. The results from 
this study suggested that abnormal growth already exists preceding the occurrence 
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of scoliosis, at least in the present animal model. 
Among the pinealectomized chickens, one of them had the delayed eccentric M-
shape-like growth with the trough at Day 13 post-op. Coincidentally, this chicken had 
the latest onset of scoliosis with a mild curvature. This observation is in concordant 
with the previous study (317) that the growth pattern is associated with the time of 
occurrence of scoliosis. Therefore, it is speculated that this chicken belonged to a 
different group and was analyzed separately. 
The scoliotic animal model adopted in this study was achieved by pinealectomy, the 
removal of pineal gland. The main product of the pineal gland is melatonin (158). 
Previous studies on scoliosis using pinealectomized chickens (272, 274) clearly 
demonstrated by radioimmunoassay that pinealectomy could successfully reduce 
the melatonin level. Apparently, the occurrence of scoliosis and any abnormality in 
growth was related to the deficiency of melatonin. In many previous studies using a 
scoliotic animal model induced by pinealectomy (274), authors often associated the 
condition of melatonin deficiency and development of scoliosis. Thillard et al. (260) 
was the first to demonstrate this relationship from his observation that 
pinealectomy could induce scoliosis in chickens. Machida et al. (268, 274) repeated 
the experiment on both chickens and bipedal rats successfully. He also discovered 
that melatonin treatment could effectively reduce the rate of occurrence of scoliosis 
in bipedal rats (268). In line with the study by Machida et al., our results 
corroborated the importance of melatonin in scoliosis development. 
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In this study, it was found that, other than producing scoliosis, the melatonin-
deficient condition also affected growth. Longitudinal bone growth is mainly 
contributed by endochondral ossification (129) which already begins at the embryo 
stage (328). During the process, the chondrocytes at the growth plate cartilage 
proliferate and become hypertrophied, which contribute to the growth in the length 
of the long bones. In this study, it was shown that melatonin could be an important 
regulator on the growth pattern of growth plate (329). 
A study by Sorrentino et al. (248) discovered that constant darkness led to a reduced 
tibial length and growth hormone (GH) level in rats, and these effects could be 
abolished by pinealectomy. Smythe et al. (249) therefore proposed that melatonin 
could modulate growth through growth hormone. The pinealectomized chickens in 
this study had a different growth rate pattern from sham chickens, indicating that 
their growth was affected. In human, growth hormone is an important modulator of 
growth and rapid growth during puberty is known to be associated with the 
development of scoliosis. In human, studies on melatonin and growth hormone are 
numerous (250, 251) and GH response to melatonin is very likely to be age- and 
puberty-related (250). Growth hormone and melatonin seem to be negatively 
correlated during childhood and prepuberty (250), while in adults, melatonin 
promotes growth hormone secretion in males but the effect is less pronounced in 
females (251). Any abnormalities in melatonin level or the consequence of its effects 
may affect growth and hence the development of scoliosis. However, very few 
studies investigating the association between melatonin, growth hormone and AIS 
were performed and their relationship is yet to be proved. 
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Melatonin is responsible for entrainment of the circadian rhythm which could 
modulate bone metabolism by influencing the secretion or action of several 
hormones and cytokines (330-332) and PTH is one of the factors. It was found that in 
mice (333), the expression of a clock gene, Per-1, was required for PTH signaling-
induced CRE dependent transcription. This formed a positive feedback loop in the 
anabolic action of PTH signaling and Per-1 in bones. Therefore, bone growth might 
be affected through the Per-l-PTH pathway if the melatonin level or the circadian 
rhythm is abnormal. Yet, the connection of the circadian rhythm and PTH-related 
pathway of bone metabolism in human needs further clarification to have this 
hypothesis recognized. 
Another phenotypic abnormality in AIS patients is lower bone mineral density (BMD). 
Previously, it was observed that BMD of cortical bone was significantly lower in AIS 
when compared with healthy control (116). Therefore, the cortical BMD of the 
chickens at midshaft of femur was measured. No significant difference was found 
between the scoliotic and non-scoliotic chickens. The study by Turgut et al. (322) 
reported a significantly lower BMD at the vertebral body in pinealectomy-induced-
scoliotic chickens 8 weeks after the operation. Besides, it was found that the mean 
total number of osteocytes and the numerical density of osteocytes and osteoblasts 
were significantly decreased in pinealectomized animals. Melatonin was shown to be 
capable of promoting osteoblast differentiation and bone formation and its essential 
role in regulating bone growth was suggested (224, 257, 325). The study by Nakade 
et al. (257) reported that melatonin stimulates the proliferation and type I collagen 
synthesis in human bone cells in vitro, suggesting that it may promote bone 
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formation. Yet, unlike the results of Turgut et al. (322), we were unable to observe 
any difference in BMD between the pinealectomized and sham chickens, probably 
because of the short duration of our experiment as BMD is under cumulative effect. 
The differences in species and habitation conditions might also account for this 
discrepancy. 
Melatonin has been believed to be one of the important factors for the 
etiopathogenesis of AIS. Pinealectomy-induced scoliosis in several animal models 
(268, 274) suggested a melatonin deficiency in AIS patients. Therefore, studies had 
been conducted to test the melatonin level in AIS girls. However, the results were 
disputable (278) and Moreau et al. (281) suggested that the problem lies at the 
melatonin signaling pathway rather than the melatonin level as he discovered that 
the melatonin signaling was impaired in the osteoblasts of AIS patients. While Man 
et al. (334) found the absence of melatonin receptor I B in a portion of girls with AIS. 
This result might explain the observation by Moreau et al. and a melatonin-deficient-
like condition may occur in AIS patients due to abnormalities of melatonin receptors. 
In this study, it was demonstrated that the abnormalities in growth of a scoliotic 
animal model could also be observed before the onset of scoliosis. The pattern 
might be associated with the time of onset and severity. This indicated that the 
abnormal growth in AIS patients might also occur before the onset of scoliosis, which 
could be useful in predicting the development and progression of scoliosis. The 
melatonin-deficient condition due to pinealectomy was a key factor in producing 
scoliosis in this chicken model. Taken together, it implied that abnormal skeletal 
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growth is important for the etiopathogenesis of AIS and is closely linked with 
melatonin signaling deficiency. Thus, while previous studies showed that AIS 
patients had no difference in serum melatonin level and exhibited abnormal 
response to melatonin with undetectable melatonin receptor, it is necessary to 





Figure 4.1 Surgical Procedures 
The chicken was anesthetized by isoflurane in oxygen throughout the operation (A). 
After sterilization, a cut was made to the skin above the superior sagittal sinus to 
expose the skull (B). A cut of 门 shape (C) was made, allowing a flap of soft bone to be 
pulled back (D). The pineal gland, which was attached to the flap of bone, was 
exposed and removed carefully. The flap of skull was replaced gently and the skin 
was sutured with 5-0 suture. 
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Figure 4.2 Radiography of chickens 
Figure 4.2A is a radiograph taken with the chicken (Day 23 post-op, sham group) 
lying on its back. This radiograph was used to monitor the development of scoliosis. 
Figure 4.2B shows the radiograph with the chicken lying on its right side. The tibia 




Figure 4.3 Histology of Chicken Pineal Gland. 
The pineal gland removed from each chicken was sectioned after fixation in paraffin 
and stained with Hematoxylin & Eosin. The above figures show the pineal gland 
under different magnification. Figure 4.3A shows that the soft tissue attached to the 
bone flap being the pineal gland, thus confirmed the complete removal of the pineal 
gland with the surgical procedures. Figure 4.3B shows the typical morphological 
characteristics of the pineal gland with follicular lumens (L) and connective-vascular 
partitions (CVP) in purple. In Figure 4.3C, besides the connective-vascular partitions 
stained in purple, a clear differentiation of the follicular (F) and parafollicular zones 
(PF) around the lumens (L) could be observed. 
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Figure 4.4 Radiograph of a pinealectomized chicken. 
7 chickens developed scoliosis within 5 weeks post-op. The above figure shows the 
radiograph of one of the pinealectomized chickens 4 weeks after the surgery. 
Scoliosis could be observed at T5-T7 region and the angle was measured by standard 
method. 
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Figure 4.5 Spine of a pinealectomized chicken with scoliosis 
The spines of chickens were obtained after sacrifice and were subjected to Micro 
computed Tomography (MicroCT) scanning for the construction of 3D images. The 
above figure shows the deformation of the spine of scoliotic chicken at T5-T7. 
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Figure 4.6 Radiograph of a chicken without pinealectomy. 
Of the 6 chickens from the sham group (without pinealectomy), none of them 
developed scoliosis throughout the whole experiment. The above figure shows the 
radiograph of a chicken 4 weeks after the sham surgery. 
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Figure 4.7 Averaged Percentage Change of Tibia Length of Chickens 
The growth rate of chickens was denoted by the percentage change of tibia length 
per day. All data were expressed as mean 土 S.D. Pinealectomized chickens in red (Px) 
and sham chickens in blue (Sham). Chickens included for the analysis were sacrificed 
at different time points. Number of chickens at all time points is 6 unless indicated 
(red for pinealectomized and blue for sham). Both groups of chickens experienced a 
rapid increase in growth rate at the beginning (to the first peak at Day 6). The growth 
rate of pinealectomized chickens dropped at Day 9 (trough) followed by an increase 
to Day 13 (second peak). This kind of M-shape-like-growth was only observed in 
pinealectomized chickens. One chicken from the pinealectomized group was 
excluded from the analysis due to its delayed M-shape-like-growth rate pattern. In 
sham chickens, the growth rate gradually decreased starting from Day 6 and no such 
eccentric growth was observed. 
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Figure 4.8 Correlation of Growth Rates with Cobb Angle of Pinealectomized 
Chickens 
The growth rates, denoted by the percentage change of tibia length, at the first peak, 
the trough and the second peak of the M-shape-like-growth in pinealectomized 
chicken (refer to Figure 4.7) were correlated with initial Cobb angle and the rate of 
change of Cobb angle. One chicken was excluded as it was an outlier. No significant 
correlation was found. 
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Figure 4.9 Percentage Change of Tibia Length of the Chicken with Delayed M-
shape-like growth 
One chicken showed a delayed M-shape-like-growth. The first peak, trough and 
second peak of the M-shape-like-growth of other pinealectomized chickens normally 
occurred at Day 6, 9 and 13 post-op respectively (refer to Figure 4.7). The growth 
rate of chicken shown above had the first peak at Day 9 post-op, trough at Day 13 
post-op and second peak at Day 16 post-op. The M-shape-like-growth was delayed 
from that of other pinealectomized chickens, (a) indicated the trough and (b) 
indicated the day of occurrence of scoliosis for other pinealectomized chickens, (c) 
indicated the onset of scoliosis for this chicken. 
92 
8 3 
I 6 ' 
.2 5 4 
I * S h a m 
2 t -
0 1 1 r~ r 
-5 0 5 10 15 20 25 30 35 40 
Days (Post-op) 
Figure 4.10 Length of Tibia of Chickens 
The length of tibia of chickens was measured twice a week on X-ray. Pinealectomized 
chickens in red (Px) and sham chickens in blue (Sham). All data were expressed as 
mean 土 S.D. Chickens included for the analysis were sacrificed at different time 
points. Number of chickens at all time points is 6 unless indicated (red for 
pinealectomized and blue for sham). One chicken from the pinealectomized group 
was excluded from the analysis due to its delayed M-shape-like-growth rate pattern. 
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Figure 4.11 Weight of chickens 
The weight of chickens was measured twice a week on an electronic balance. All 
data were expressed as mean 土 S.D. Pinealectomized chickens in red (Px) and sham 
chickens in blue (Sham) Chickens included for the analysis were sacrificed at 
different time points. . Number of chickens at all time points is 6 unless indicated 
(red for pinealectomized and blue for sham). One chicken from the pinealectomized 
group was excluded from the analysis due to its delayed M-shape-like-growth rate 
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Figure 4.12 Cross-sectional study of BMD of chickens. 
Chickens from the pinealectomized (n=12) and sham (n=8) groups were sacrificed at 
different time points and their BMD at right femur shaft was measured by microCT. 
The BMD of both groups increased with age. Both the endpoint and the rate of 
increase of BMD were similar between the pinealectomized and sham groups. 
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Table 4.1 Time Points for Sacrifices of Chickens 
Days post-op 
Group 0 2 6 9 13 16 20 23 27 30 34 
Pinealectomized 1 1 2 1 1 - 1 1 4 
(11) (10) (9) (8) (8) (7) (6) (6) (5) (4) (0) 
Sham 1 1 - - - 2 - - - 4 
(7) (7) (6) (6) (6) (6) (4) (4) (4) (4) (0) 
Chickens f rom both the pinealectomized and sham groups were sacrificed at 
different t ime points for the cross- sectional analysis of bone mineral density. The 
table above documents the number of chickens sacrificed at each t ime points. 
Values in brackets indicate the number of chickens remained at that t ime point. Only 
chickens kept for 16 days post-op (i.e. 7 Pinealectomized and 6 Sham chickens) were 
included for longitudinal analysis. 
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Table 4.2 Occurrence of Scoliosis 
^ ^ ^ ^ ^ ^ ^ ^ ~ ~ _ _ D a y s post-op 6 9 13 16 20 23 
Group � � — - - - - � _ _ 
Pinealectomized (n=7) - 1 5 - - 1 
Sham (n=6) -
Seven chickens f rom the pinealectomized group developed scoliosis within the 5-
week experiment. Six of them developed scoliosis within Day 13 post op and the 
remaining one at Day 23 post-op. Scoliosis was not observed in any of the chickens 
f rom the sham group. 
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Table 4.3 Cobb Angle of Pinealectomized Chickens 
Days Rate of 
post- Change 
op of Cobb 
Angle 
Chicken 9 13 16 20 23 27 30 34 (/day) 
COOl - 21.7 28.6 33.2 35.3 1.26 
C002 - 27.5 28.4 39.8 42.5 44.7 ^ L I Z 
C003 - 17.5 20.3 * * * * 
C004 - 19.5 20.1 30 32.8 33.2 39.2 41.6 1.15 
COOS 23.6 25.6 27.6 30 34.4 38.6 " * * 
C006 - 17.7 20.3 23.5 25.8 27.5 28.7 30.8 0.61 
C007 - 41.4 43.4 47.8 63.8 67.8 74 ^ 2 m 
Radiograph of each chicken was taken twice a week. The Cobb angle was measured 
on the radiograph with the chicken at the supine position. The table lists the Cobb 
angle of pinealectomized chicken at each t ime point and the rate of change of Cobb 
angle. Boxes marked wi th (*) indicate that the chicken had already been sacrificed 
while the box marked with ( ** ) indicates a missing data. 
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Table 4.4 Occurrence of M-shape-like growth" 
Group Occurrence of M- Day post-op of occurrence of the trough 
shape-like growth" of M-shape-like growth" 
^ [ I 3 
Pinealectomized 7 6 (a) 1 (b) 
(n=7) 
Sham (n=6) 0 0 0 
All the pinealectomized chickens showed a M-shape-like growth while none of the 
sham chickens showed this phenomenon. Most of the pinealectomized chickens (6 
out of 7) demonstrated a M-shape-like-growth between Day 6 and 13, wi th a sudden 
drop at Day 9. For the remaining chickens, the trough occurred at Day 13 instead and 
scoliosis developed at Day 23, in contrast to Day 13 like the other pinealectomized 
chickens. 
(a) All chickens developed scoliosis within Day 13 post-op 
(b) The chicken developed scoliosis at Day 23 post-op 
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Table 4.5 Test of Within-Subjects Contrast of Growth rate 
Mean Square p-value 
Day Linear 0.771 0.312 
Quadratic 1.316 0.048* 
Day * Group Linear 0.466 0.428 
Quadratic 4.425 0.002* 
The growth rate of chickens was denoted by the percentage change of tibia length 
per day. The effect on the pattern of growth rate of Day (Day 6 to 13 post-op) and 
group together were significant (*) in a quadratic manner. 
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Table 4.6 Comparison of growth rate between pinealectomized and sham chickens 
at different time points 
Day post-op Pinealectomized Sham (n=6) p-value 
(n = 6) 
Day 6 4.45 土 0.48 4.30 ± 1.26 0.786 
Day 9 3.26 ± 0.53 4.32 ±0.57 0.008 
Day 13 4.38 ±0.45 3.66 ±0.47 0.023 
The growth rate of chickens was denoted by the percentage change of tibia length 
per day. All data were expressed as mean 土 S.D. The growth rate of pinealectomized 
chickens was significantly lower than sham chickens at Day 9 as most of the 
pinealectomized chickens experienced a sudden drop in growth rate at Day 9. This 
sudden drop in chickens f rom the pinealectomized group was fol lowed by a rapid 
increase in growth rate at Day 13, while the growth rate of sham chickens gradually 
decreased. This resulted in a significantly higher growth rate in pinealectomized 
chickens. 
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AIS is very likely a multifactorial disease and its etiology still remains unknown (134). 
Yet, it is generally believed that hormonal dysfunction is associated wi th the etiology 
of AIS (134). Melatonin is one of the factors wi th increasing interest due to the 
recent findings on the relationship between melatonin and AIS patients. (172, 272-
275, 277, 335). In Chapter 4, a scoliotic chicken model produced by the removal of 
melatonin producing gland was adopted for the study of growth pattern and was 
found that it could create an abnormal growth pattern which coincided wi th the 
occurrence of scoliosis. Machida et al. (268, 274, 320) were able to produce a 100% 
success rate of scoliosis induction by pinealectomy in chickens and bipedal rats. In 
these studies, the melatonin levels in pinealectomized chicken were restored by 
injecting melatonin (274) or feeding melatonin pellets (268). All these actions could 
significantly reduce the rate of occurrence of scoliosis in chickens. These evidences 
further corroborated that melatonin does play a role in the etiopathogenesis of AIS. 
There were studies on serum melatonin level in AIS girls (130, 276, 278, 279) but the 
results were contradicting. Some found a significantly higher serum melatonin level 
in progressive AIS patients than normal control (276), while others could not observe 
any difference (130, 278). On the other hand, the study by Moreau et al. (281) found 
that there was melatonin signaling dysfunction in the osteoblasts from AIS patients. 
The osteoblasts f rom AIS patients failed to inhibit forskolin-stimulated cyclic AMP 
under the stimulation of melatonin, unlike normal controls. Man et al. (283) 
examined the proliferation and differentiation ability of osteoblast upon the addition 
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of melatonin. It was found that, while melatonin had a stimulatory effect on the 
proliferation and differentiat ion of osteoblasts from normal controls, those from AIS 
patients were not responsive or even showed a negative response. Man et al. (283) 
speculated that there was abnormal expression of melatonin receptor in AIS patients, 
which might lead to melatonin signaling dysfunction, and affect the response of 
osteoblasts towards melatonin. 
In another study in our center, it was found that a polymorphism (SNP) at the 
promoter region of melatonin receptor IB (MTNRIB) polymorphism was associated 
wi th the occurrence of AIS (92). The authors suggested that the polymorphism at 
promoter region may lead to a decrease in expression of MTNRIB and hence its 
functional deficiency. However, the gene was not associated with curve severity and 
therefore it was suggested that MTNRIB might be a disease predisposition gene. The 
studies of gene polymorphism of MTNRIB were repeated by other groups but the 
results were not consistent. This may be due to sample size problem, ethnical 
difference, or irrelevant control subjects problem. However, in the Chinese 
population, it was further found in a recently study with small sample size (334) that 
melatonin receptor IB was absent in about 30% of AIS patients wi th abnormal 
response to melatonin. It further supported the hypothesis that the abnormality lies 
at the melatonin receptor instead of melatonin level. 
Although the exact relationship between melatonin signaling and scoliosis 
development is still not known, it is quite certain that melatonin plays a vital role in 
the development of scoliosis f rom previous chapter and other animal studies (262, 
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268, 274). Since the abnormal expression of melatonin receptors could directly 
affect melatonin signaling pathway and hence the effect of melatonin, it is necessary 
to further investigate the expression of melatonin receptor in osteoblasts of AIS, in 
terms of both protein and mRNA level, to account for the findings of melatonin 
signaling dysfunction in osteoblast in AIS patients. 
With the observation of the abnormal growth patterns in AIS girls (Chapter 3) and 
the abnormal growth pattern induced by pinealectomy in chickens which leads to 
scoliosis (Chapter 4), the present study aimed to study the possible abnormality in 
melatonin receptor expression in AIS girls wi th a larger sample size. 
5.2 Methodology 
5.2.1 Subjects Recruitments 
Forty-one severe cases of AIS patients were recruited from the Prince of Wales 
Hospital and Drum Tower Hospital, Nanjing within the study period. Their status of 
scoliosis was diagnosed by clinical examination and standard standing 
posteroanterior x-ray. Patients wi th disease other than idiopathic scoliosis, or 
scoliosis of congenital, neuromuscular, metabolic etiology, skeletal dyplasia and 
known endocrine and connective tissue abnormalities or wi th medications were 
excluded from the study. The clinical data related to the AIS patients is listed in 
Table 5.1. Informed consents to obtain bone biopsy during operation were acquired 
before the surgery. 
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Due to the difficulty to recruit age-matched adolescents who required surgical 
treatment after trauma, the best number of bone biopsies obtained during the study 
period was nine normal controls aged between 12 and 24 who underwent surgery 
for trauma-related condition (Table 5.2). The absence of scoliosis, spinal problem 
and other bone metabolic diseases were confirmed by experienced orthopedic 
surgeons before operation. Consents f rom these normal subjects were obtained. 
Details of the research and biopsy collection were given to all the subjects and their 
parents before they entered the study. 
5.2.2 Cell Isolation 
5.2.2.1 Bone Biopsies for Osteoblasts Isolation 
Bone biopsies were collected f rom iliac crests or facet joints of the AIS patients. For 
normal controls, bone biopsies were collected from the site of surgery. As the site 
was isolated directly f rom bone pieces, there should be no variability on in vivo 
biomechanical changes. The research protocol had been approved by the Clinical 
Research Ethics Committee of the University. 
5.2.2.2 Materials and Reagents 
Phosphate Buffered Saline (PBS) 
1.44 g Na2HP04(Merck & Co., Darmstadt, Germany), 0.24 g KH2PO4(Merck & Co., 
Darmstadt, Germany), 8.0 g NaCI (Merck & Co., Darmstadt, Germany) and 0.2 g KCI 
(Merck & Co., Darmstadt, Germany) were dissolved in 900 ml distilled water. The pH 
was adjusted to 7.4 and the final volume was made up to 1000 ml wi th distilled 
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water. The solution was sterilized by autoclaving and stored at 
Dulbecco's modified Eagle's medium (DMEM) 
One pack of DMEM (Invitrogen, Carlsbad, USA), 2.2 g NaHCOg (Riedel-de Haen, 
Seeize, Germany) and 0.1 g D-valine (Sigma, St.Louis, USA) were dissolved in 800 ml 
distilled water. The pH was adjusted to 7.4 and the final volume was made up to 
1000 ml with distilled water. The solution was passed through a bottle top fi lter. 
5.2.2.3 Isolation of Osteoblasts from Bone Biopsies 
Bone biopsies were first washed with plain DMEM with 10% penicillin-streptomycin-
neomycin (PSN) antibiotic mixture (Invitrogen, Carlsbad, USA) to avoid any 
contamination. Trabecular bones f rom the biopsies were cut and minced into small 
pieces with a sharp bone cutter under sterile conditions. The fragments were then 
gently rinsed wi th sterile PBS to remove excess blood and plated onto a 6-well 
culture plate (Corning, New York, USA) which is shown in Figure 5.1 (A) in DMEM 
(Invitrogen, Carlsbad, USA) supplemented with 10% Fetal Bovine Serum (FBS) 
(Invitrogen, Carlsbad, USA) and 1% PSN (Invitrogen, Carlsbad, USA). The culture was 
maintained at 37°C in a humidified atmosphere of 5% CO〗. The medium was 
renewed every 2-3 days. Cells were harvested and passed to a 150 cm^ flask (Corning, 
New York, USA) when they reached 90% confluence. Only the first and second 
passages of the cells were used for assessment. Figure 5. IB shows the cell 
morphology of osteoblasts in one of the subjects. 
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5.2.3 Expression Level and Pattern of Melatonin Receptors l A and I B 
The quantif ication of melatonin receptors l A and IB protein expression and mRNA 
expression on osteoblasts of AIS patients were done by Western blott ing and real 
t ime polymerase chain reaction, respectively. The expression levels were compared 
with normal controls. A pilot study on localization of melatonin receptors was 
performed by fluorescence immunocytochemistry wi th confocal microscopy. To 
prove the specificities of the antibodies used and also the validity of the experiments 
of Western blotting and immunocytochemistry, co-immunoprecipitation was 
performed before hand using different antibodies. 
5.2.3.1 Materials and Reagents 
50% Protein A-Sepharose Bead Slurry 
0.1 g bovine serum albumin (BSA) (Sigma, St. Louis, USA) and 0.01 g of sodium azide 
(Sigma, St. Louis, USA) were dissolved in 10ml of PBS. 50 ^ o f this mixture was used 
to dilute 50 ^ o f protein A-Sepharose (Sigma, St. Louis, USA). 
Non-Denaturing Lysis Buffer 
935 ^ of Triton X-100 (VWR, PA, USA), 1.75 g of sodium chloride (Merck & Co., 
Darmstadt, Germany), 0.146 g of EDTA, 0,02 g of sodium azide was dissolved in 
100ml 50 m M Tris-HCI (pH 7.4) (Sigma, St.Louis, USA). The lysis buffer was stored at 
4。C and used within 6 month. 
Wash Buffer 
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93.5 of Triton X-100, 1.75 g of sodium chloride (Merck & Co., Darmstadt, 
Germany), 0.146 g of EDTA, 0,02 g of sodium azide was dissolved in 100ml 50 m M 
Tris-HCI (pH 7.4) (Sigma, St.Louis, USA). The wash buffer was stored at 4°C and used 
within 6 months. 
6xSDS Gel Loading Buffer 
1 mg bromophenol blue (Merck & Co., Darmstadt, Germany) was dissolved in 3.5 ml 
I M Tris-HCI (pH 6.8) (Sigma, St.Louis, USA). 1 g of sodium dodecyl sulfate (SDS) 
(Amresco, Solon, USA) and 3 ml glycerol (Amresco, Solon, USA) were added to the 
solution. The mixture was aliquoted. 0.214 ml of p-mercaptoethanol (Merck & Co., 
Darmstadt, Germany) was added to every 0.781 ml and used within 2 weeks. 
4% Stacking Gel 
0.33 ml of 30% acrylamide solution (0.3 g/ml acrylamide, 8 g/ml of N, N'-methylene 
bisacrylamide) (GE Healthcare, Bucks, UK), 0.625 ml 0.5M Tris-HCI (pH 6.8) (Sigma, 
St.Louis, USA), 25 of 10% SDS (Amresco, Solon, USA) and 1.505 ml of deionized 
water were mixed gently. 2.5 \i\ TEMED (Merck & Co., Darmstadt, Germany) and 
12.5 ^il of 10% ammonium persulfate (Sigma, St.Louis, USA) were added to the 
mixture right before loading the gel onto the casket. 
10% Separating Gel 
1.67 ml of 30% acrylamide solution (0.3 g/ml acrylamide, 8 g/ml of N, N'-methylene 
bisacrylamide) (GE Healthcare, Bucks, UK), 1.25 ml 1.5M Tris-HCI (pH 8.8) (Sigma, 
St.Louis, USA), 50 \x\ of 10% SDS (Amresco, Solon, USA) and 2 ml of deionized water 
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were mixed gently. 5 ~I TEMEO (Merck & Co., Oarmstadt, Germany) and 25 ~I of 10% 
ammonium persulfate (Sigma, St.Louis, USA) were added to the mixture right before 
loading the gel onto the casket. 
SOS Running Buffer 
3.0 g Tris Base (Sigma, St. Louis, USA), 14.4 g glycine (Amresco, Solon, USA) and 1.0 g 
SOS (Amresco, Solon, USA) were dissolved in 800 ml deionized water. The solution 
was mixed gently and the pH was adjusted to 8.3. The final volume was made up to 
1000 ml with deionized water. 
Tris-Buffered Saline with Tween-20 (TBST) 
8.8 g NaCI (Merck & Co., Oarmstadt, Germany), 0.2 g KCI (Merck & Co., Oarmstadt, 
Germany) and 3 g Tris base (Amresco, Solon, USA) were dissolved in 800 ml distilled 
water. 1 ml of Tween-20 (Amresco, Solon, USA) was added and the solution was 
mixed gently. The pH was adjusted to 7.4 and the final volume was made up to 1000 
ml with distilled water. The solution was sterilized and stored at 4°C. 
5% Skimmed Milk 
2.5 g of skimmed milk powder was dissolved in 50 ml TBST. The diluted skimmed 
milk was mixed gently and stored at 4°C and used within 3 days. All the primary and 
secondary antibodies were diluted with 5% skimmed milk. 
Primary Antibody 
Goat lgG anti-human Melatonin Receptor lA antibody (Abeam, Cambridge, England) 
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was di luted at a ratio of 1:800 by 5% skimmed milk for Western blott ing and 1:400 
by 1% bovine serum albumin (BSA) (Sigma, St.Louis, USA) for immunofluorescence; 
Rabbit IgG anti-human melatonin receptor IB antibody (Novus Biologicals, Littleton； 
USA) was di luted at a ratio of 1:2000 by 5% skimmed milk for Western blott ing and 
1:400 by 1% Bovine Serum Albumin (BSA) for immunofluorescence; Goat IgG anti-
human actin (Abeam, Cambridge, England) was diluted at a ratio of 1:5000 wi th 5% 
skimmed milk for Western blott ing and wi th 1% bovine serum albumin (BSA) for 
immunofluorescence. Polyclonal antibodies directed against the human melatonin 
receptors l A and IB raised in rabbit by means of antigenic synthetic peptides (336) 
(a gift f rom Prof. Fraschini) was diluted at a ratio of 1:800 wi th 5% skimmed milk for 
co-immunoprecipitat ion. 
Secondary Antibody 
Goat anti-rabbit IgG (Abeam, Cambridge, England) was diluted at a ratio of 1:5000 
wi th 5% skimmed milk for Western blott ing; Donkey anti-goat IgG (Santa Cruz, Santa 
Cruz, USA) was diluted at a ratio of 1:5000 wi th 5% skimmed milk for Western 
blott ing; Alexa Fluor® 488 chicken anti-rabbit IgG (Invitrogen, Carlsbad, USA) was 
diluted at a ratio of 1:400 wi th 1% bovine serum albumin (BSA) for 
immunofluorescence; Alexa Fluor® 555 donkey ant卜goat IgG (Invitrogen, Carlsbad, 
USA) was diluted at a ratio of 1:400 wi th 1% bovine serum albumin (BSA) for 
immunofluorescence 
TaqMan Gene Expression Assay 
Melatonin Receptor l A TaqMan Gene Expression Assay; Assay id: Hs00195567_ml* 
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(Applied Biosystem, California, USA) 
Melatonin Receptor IB TaqMan Gene Expression Assay; Assay id: Hs00173794_ml* 
(Applied Biosystem, California, USA) 
Made to Order TaqMan Gene Expression Assay (N-terminal Extracellular Domain of 
Melatonin Receptor IB; Assay id: AJWRIOX (Applied Biosystem, California, USA) 
Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) TaqMan Gene Expression 
Assay; Assay id: Hs03929097_gl (Applied Biosystem, California, USA) 
4% Paraformaldehyde 
2 g of paraformaldehyde (Sigma, St.Louis, USA) was added to 40ml of PBS. The 
solution was heated to 60°C to dissolve the paraformaldehyde powder. The mixture 
was allowed to cool to room temperature. The pH of the solution was adjusted to 
7.2 and the final volume was made up to 50 ml. The solution was used within a few 
days. 
0.25% Triton X-100 
0.125 ml of Triton X-100 (BDM Laboratory, Poole, England) was added to 49.9 ml of 
PBS to make up a final volume of 50 ml. The solution was mixed thoroughly by 
inverting a few times and stored at room temperature. 
90% Glycerol 
The pH of 45 ml glycerol (Amresco, Ohio, USA) was adjusted to 8.0. The final volume 
was made up to 50 ml wi th PBS. The solution was stored at room temperature 
112 
5.2.3.2 Validation of Specificities of Antibodies by Co-immunoprecipitation 
The antibody-conjugated beads were first prepared by combining 30 pil of 50% 
protein A-Sepharose bead slurry, 0.5 ml ice-cold PBS and the selected antibody (2 
of Goat IgG anti-human Melatonin Receptor l A antibody (Abeam, Cambridge, 
England) or 1 ^ of Rabbit IgG anti-human melatonin receptor IB antibody 
(Novus Biologicals, Littleton, USA) which would be used for Western blotting and 
immunofluorescence) in a 1.5-ml microcentrifuge tube. The suspension was mixed 
thoroughly and tumbled end over end in a tube rotator for 1 hour at 4°C. The 
mixture was then centrifuged at 13200 rpm for 2 seconds at 4°C and supernatant 
was aspirated afterwards. 1 ml non-denaturing lysis buffer was added to the tube to 
resuspend the beads. The above two steps were repeated for 2 times and the 
resuspension step was skipped for the last t ime. The beads were kept on ice until 
use. 
MG63, a human osteoblastic cell line expressing both MTNRIA and IB (337), was 
used as a sample to test the specificities of antibodies. The cells were cultured as 
mentioned previously and were detached and collected from the culture flask upon 
reaching confluence by 0.25% trypsin (Invitrogen, Carlsbard, USA) and washed twice 
with ice-cold PBS in a 15-ml falcon (BD Biosciences, New Jersey, USA). 1 x 10^ cells 
were collected in a l.Sml-microcentrifuge tube. 1 ml ice-cold non-denaturing lysis 
buffer was added and the cells were resuspended by gentle agitation and kept 
suspended on ice for 15 minutes. The lysate was cleared by centrifugation at 13,200 
rpm for 15 minutes at 4°C. The supernatant (about 1 ml) was collected and 
combined with 30 ^il of 50% protein A-Sepharose bead slurry in a 1.5-ml 
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microcentr i fuge tube and tumbled in a tube rotator for 30 minutes at 4°C. The 
mixture was then centrifuged at 13200 rpm for 5 minutes at 4°C. 
10 |il of 10% bovine serum albumin (BSA) (Sigma, St. Louis, USA) in PBS was added to 
the ant ibody-bound protein A-Sepharose beads prepared previously and the entire 
volume of cleared lysate was transferred to the tubes w i th the beads. The mixture 
was incubated at 4°C for 2 hours whi le mixing end over end in a tube rotator. The 
suspension was then centrifuged at 13200 rpm for 5 seconds at 4°C and supernatant 
was aspirated afterwards. 1 ml ice-cold wash buffer was added to the tube to 
resuspend and wash the beads. The mixture was centrifuged again at 13200 rpm for 
2 seconds at 4°C and supernatant was aspirated. The above two steps were repeated 
for 3 times. The beads were washed once more using 1 ml ice-cold PBS wi th the 
above steps. 
The ant ibody-bound beads w i th target protein attached were then subjected to SDS-
PAGE and Western blott ing and tested w i th di f ferent antibodies (polyclonal rabbit 
ant i-human melatonin receptor l A and I B antibodies, a gift f rom Prof. Fraschini 
(336)). The protein was di luted w i th 0.5 ml PBS and 20 [x\ of the mixture was used to 
prepare for 1 sample by adding 4 of 6X SDS gel loading buffer to make up a final 
volume of 24 \x\. The samples were boiled for 5 minutes in water bath to denature 
the protein. Afterwards, 20 |il of the mixture was separated by SDS-PAGE (Bio-Rad； 
Hercules, USA) w i th 10% separating gel and 4% stacking gel for I h r 30 minutes at 
lOOV. The gel w i th separated protein was removed and electro-blotted by semi-dry 
method for 20 minutes at 500 mA onto a nitrocellulose membrane (Hybond-ECL; GE 
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Healthcare, Bucks, UK) which was activated by methanol right before used. The 
membrane was washed three times with TBST buffer after the transfer and blocked 
with 5% fat-free milk for 1 hour at 4°C. The membrane was then probed wi th the 
selected anti-human primary antibodies overnight at 4°C. The probed membrane 
was washed three times wi th TBST buffer and incubated wi th horseradish 
peroxidase-conjugated goat anti-rabbit secondary antibody for 1 hour at 4°C, 
fol lowed by three washes using TBST again. The immunocomplex was visualized 
using ECL Western Blotting Detection Reagents (GE Healthcare, Bucks, UK) on a 
medical X-ray fi lm (Fujifilm, Tokyo, Japan) for 15 minutes. 
5.2.3.3 Quantification of Protein Expression of Melatonin Receptors in Osteoblasts 
Cells were cultured as mentioned previously and the second passage of cells was 
used. Cells were detached and collected from the culture flask by 0.25% trypsin and 
washed twice wi th ice-cold PBS in a 15-ml falcon. 1-2 x 10^ cells were collected in a 
l.Sml-microcentrifuge tube and were lysed in RlPA buffer (Sigma, St.Louis, USA) 
containing 1 m M protease inhibitor cocktail (Sigma, St.Louis, USA) and 1 mM PMSF 
(Sigma, St.Louis, USA). Cells were further lysed by pipetting up and down through a 
syringe and incubated in RlPA buffer for 30 minutes. The mixture was centrifuged at 
13,200 rpm for 15 minutes at 4°C. The supernatant was collected and stored at -
80°C until use. For Western blotting, 36 \xg of the extracted protein f rom the 
supernatant was used to prepare for 1 sample by adding water and 4 |al of 6X SDS gel 
loading buffer to make up a final volume of 24 |il. The samples were boiled for 5 
minutes in water bath to denature the protein. Afterwards, 20 |il of the mixture (30 
|ig protein) was separated by SDS-PAGE with the protocol mentioned above. For 
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each gel, same amount of protein extracted from the cell line MG63 was used as 
positive control and loaded to allow comparison within each experiment. After 
Western blotting, the membrane was then probed with the selected anti-human 
primary antibodies overnight at 4°C The probed membrane was washed three 
times wi th TBST buffer and incubated wi th selected horseradish peroxidase-
conjugated secondary antibody for 1 hour at 4°C, fol lowed by three washes using 
TBST again. The immunocomplex was visualized using ECL Western Blotting 
Detection Reagents (GE Healthcare, Bucks, UK) on a medical X-ray film (Fujifilm, 
Tokyo； Japan) for 5 minutes (melatonin receptor lA ) or 15 minutes (melatonin 
receptor IB). 
To control and correct for protein loading error and allow comparison between 
bands, beta-actin was adopted as the internal control. The same membrane, after 
the analysis of the first antibody, was washed 3 times with TBST buffer and then 
incubated wi th an anti-actin antibody at 4°C overnight. After another 3 washes wi th 
TBST, it was incubated with horseradish peroxidase-conjugated donkey anti-goat 
secondary antibody for 1 hour at 4°C. As before, after conjugation wi th a secondary 
antibody, it was visualized using ECL Western Blotting Detection Reagents (GE 
Healthcare, Bucks, UK) on a medical X-ray fi lm (Fujifilm, Tokyo, Japan). An affinity-
isolated antigen-specific antibody directed against the actin protein (Santa Cruz, 
Santa Cruz, USA) was used as a reference protein for semi-quantification of the 
Western blots. Band intensity was obtained by an image analysis software, ImageJ 
(v.1.43, NIH, USA). The signal intensity of each sample was corrected by beta-actin. 
Relative intensity was then calculated by dividing the corrected band intensity of 
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band of interest by that of MG63, which allowed the comparison among membranes. 
All experiments were performed in duplicate. 
5.2.3.4 Quantification of mRNA Expression of Melatonin Receptor in Osteoblast 
Cells were cultured as mentioned previously and the second passage of cells was 
used. Cells were detached and collected from the culture flask by 0.25% trypsin and 
washed twice with ice-cold PBS. Approximately 5 x 10^ cells were used for mRNA 
extraction. mRNA was extracted from cells using QIAGEN RNeasy Extraction Kit 
(Qiagen, Hilden, Germany) according to the manufacturer's instructions. mRNA 
concentration of each sample was determined by Nanodrop (Thermo Fisher 
Scientific, Massachusetts, USA). 2 jig of total RNA was used for reverse transcription 
reaction. For each reaction, the mRNA was first mixed with 1 |il of 10 mM dNTP 
(Promega, Fitchburg, Wisconsin), 30 ng of oilgo dT (Invitrogen, Carlsbad, USA), 20 
units of RNase inhibitor (Invitrogen, Carlsbad, USA) and DEPC-H2O to make up 15.5 [x\. 
The mixture was heated at 72°C for 5 minutes using a PGR machine and quickly 
cooled down to 4°C on ice. Afterwards, 100 units of reverse transcriptase (Promega, 
Fitchburg, Wisconsin) and 4 |il of 5X reaction buffer (Promega, Fitchburg, Wisconsin) 
were added to the mixture which made the final volume to 20 |il. This final mixture 
was heated at 42°C for 1 hour and then 94。C for 10 minutes in a PGR machine. The 
cDNA product was stored at -SCTC until use. 
The Real Time PGR Reaction was performed with TaqMan Gene Expression Assay. 
For melatonin receptor lA , a pre-made TaqMan Gene Expression Assay (Assay id: 
Hs00195567_ml*) was used. For melatonin receptor IB, a custom-made assay 
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(Assay id: AJWRIOX) flanking the N-terminal extracellular domain was adopted and a 
pre-made assay (Assay id: Hs00173794—ml*) f rom the across-exon region of 
melatonin receptor IB was used to confirm the results. A pre-made assay of GAPDH 
(Assay id: Hs03929097_gl), a house-keeping gene, was used as the endogenous 
control to correct for the loading error and difference in cDNA concentration 
between samples. The PGR reaction was performed on a 7900HT Fast Real-Time PGR 
System (Applied Biosystem, California, USA) using a 384-well plate. Each PGR 
reaction mix consisted of 1 |il of 20X TaqMan Gene Expression Assay, 10 ^il of 2X 
TaqMan Gene Expression Master Mix, 4 |il of the cDNA product and 5 |il of RNase-
free water, which made up the final volume to 20 |il per well. All samples were run in 
duplicate. The condition for the PGR reaction was optimized according to 
manufacturer's guidelines, which consisted of 10 minutes of Polymerase Activation, 
and 40 cycles of denaturation (15 seconds) and annealing/Extending (1 minute). 
Relative quantification of mRNA of melatonin receptors was done using RQ manager 
(Applied Biosystem, California, USA) and SDS software (Applied Biosystem, California, 
USA). The threshold and threshold cycle (CT) of each reaction was automatically 
determined by RQ manager whereas the Relative Quantification (RQ) value was 
calculated by the SDS software. The algorithm was as follows: Delta CT (ACT) = CT of 
target gene - CT of endogenous control (GAPDH); Delta Delta CT (AACT) = -(ACT of 
sample-ACT of calibrator sample); Relative Quantification, or RQ value = 2-AACT. The 
calibrator sample was a normal control sample. The RQ values were expressed in log 
to obtain a normal distribution for analysis. 
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5.2.3.5 Localization of Melatonin Receptor l A and I B by Immunofluorescence 
Staining 
Osteoblasts were seeded on Poly-L-lysine (Sigma-Aldrich, MO, USA) coated 
coverslips at a density of 5000 cells/coverslip. Cells were cultured for 2 days until the 
cells had stabilized and attached to the coverslips. After brief washing wi th PBS 
briefly twice, the cells on coverslips were fixed with 4% paraformaldehyde solution 
for 15 minutes at room temperature. Cells were rinsed twice wi th cold PBS at 4°C. To 
permeabilize the cells, they were incubated wi th 0.25% Triton X-100 for 15 minutes 
at room temperature and then washed three times with PBS. After blocking non-
specific binding wi th 1% BSA/PBS for 30 min at room temperature, the cells were 
incubated overnight wi th primary antibodies at 4°C in a moist chamber. Primary 
antibodies were diluted in 1% BSA/PBS. The cells were then quickly rinsed three 
times with PBS and washed twice wi th PBS for 5 minutes each. They were then 
incubated wi th the appropriate Alexa Fluor* secondary antibodies diluted in 1% 
BSA/PBS for 1 hour at room temperature in complete darkness. After the incubation, 
the samples were quickly rinsed three times with PBS and washed 2 times with PBS 
for 5 minutes each and air-dried. A drop 90% glycerol in PBS was added to the cells. 
The cover slips were mounted on glass slides with nail polish. 
Fluorescence immunocytochemistry was analyzed at 400x wi th a confocal 
microscopy (LMS META 510 confocal imaging system, Carl Zeiss, Hercules, 
Oberkochen, Germany). The wavelengths ( A) for f luorochrome excitation were 488 
nm (for Alexa Fluor* 488) and 555 nm (for Alexa Fluor" 555), respectively. Images 
were acquired with the system built-in image-capturing device. Descriptive analysis 
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was carried out. 
5.2.4 Evaluation and Correlation of Clinical Phenotypes with Melatonin Receptor 
Expression 
The anthropometric parameters, body weight (BW), body mass index (BMI) and arm 
span were measured at our research centre using standard methods as stated in 
Chapter 3. Body mass index (BMI) was calculated by dividing weight (kg) by square of 
arm span (m^ (Weight [kg] / Square of Height [m^]). The measurements were 
reference to the normal healthy adolescent girls database at our centre and 
converted to age-matched z-scores for comparison between subjects at different 
ages. The AIS patients were separated into two groups according to their mRNA 
expression level of melatonin receptor (normal or low), using the minimum value of 
expression level of normal controls as a reference line. The z-scores of different 
parameters were compared between the two groups. 
5.2.5 Data Analysis 
The normalized values of band intensity f rom Western Blot and log of RQ values 
什om RT-PCR of AIS and normal controls were analyzed by independent sample 
Student's t-test. The z-scores of the anthropometric parameters of AIS patients were 
compared against normal adolescent girls by one sample t-test to test for deviation 
from zero as it is the z-score of the normal population. Independent sample 
Student's t-test was used to compare the z-scores between groups of AIS patients 
with different expression level of melatonin receptors. The data were expressed as 
mean 土 S.D. Difference was considered statistically significant when p < 0.05. SPSS 
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16.0 (SPSS Inc., Chicago, IL) was used for statistical analysis. 
5.3 Results 
5.3.1 Protein Expression of Melatonin Receptor l A and I B 
The antibodies used were validated by co-immunoprecipitation fol lowed by SDS-
PAGE and Western blot. Figure 5.2 shows the membrane with specific bands for both 
MTNRIA and IB, proving the validity of the antibodies. The full-length images of 
Western blot are shown in Figure 5.3. The Western blot signals of representative 
samples of melatonin receptors of normal controls and AIS patients are shown in 
Figure 5.4 and Figure 5.5, respectively. Comparison between AIS group and control 
group disclosed that the intensity of melatonin receptor l A was similar between the 
two groups (p=0.81) using independent sample Student's t-test (Figure 5.6). 
However, the expression of melatonin receptor IB in AIS group was significantly 
lower than that in the control group (p=0.02) (Figure 5.7). 
5.3.2 mRNA Expression of Melatonin Receptor l A and I B 
As a lower protein expression of melatonin receptor IB was found in AIS patients, 
focus was placed on this receptor, and 2 primers f rom different regions (extracellular 
domain and across-exon region) were used to confirm and validate the results. 
Figure 5.8 shows the relative quantification value of melatonin receptor IB using 
primer f rom the extracellular domain against that f rom the across-exon region. It 
showed a relative high correlation (R^=0.6183), and a correlation test gave a 
significant value (p=0.0013), indicating that both primers are specific to melatonin 
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receptor IB and the results were valid. As the experiment using primer from the 
extracellular domain had a higher CT value, which could theoretically give more 
accurate result, results f rom this experiment were used for comparison of 
expression of melatonin receptor IB between AIS and control groups. 
The comparison of mRNA expression of melatonin receptor l A and IB between AIS 
and control groups were displayed in Figure 5.9 and Figure 5.10, respectively. The 
mRNA expression of melatonin receptor IB of AIS patients was significantly lower 
than control (p=0.0192). 12 out of 41 AIS patients (29%) had an expression level 
lower than the minimum of normal controls. The mRNA expression of melatonin 
receptor l A was similar between the two groups (p=0.707). 
5.3.3 Localization of Melatonin Receptors l A and I B 
Figure 5.11 shows the distribution of melatonin receptors l A and IB on the cell 
membrane of osteoblasts. For both AIS patients (Figure 5.11A, C, E) and normal 
control (Figure 5.11B, D, F). Melatonin receptor l A (Figure 5.11A, B) and IB (Figure 
5 . l i e , D) were distributed evenly on the cell surface and co-localization of the two 
receptors was not observed (Figure 5 .HE, F). The area of the red signal obtained for 
melatonin receptor l A expression on cell membrane ranged from 0.29-0.45 
where as that of melatonin receptor IB was about 0.03 | i m l 
Figure 5.12 shows the distribution of melatonin receptors l A and IB inside the 
osteoblasts under permeabilized conditions. The pattern was similar for both AIS 
patients (Figure 5.12A, C, E) and normal controls (Figure 5.12B, D, F), Melatonin 
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receptor l A (Figure 5.12A, B) was distributed evenly inside the nucleus. Condensed 
clusters of melatonin receptor IB (Figure 5.12C, D) were observed inside the nucleus. 
Similarly, no co-localization of the two receptors was observed (Figure 5.12E, F). 
5.3.4 Evaluation and Correlation of Clinical Phenotypes with Melatonin Receptor 
Expression 
Table 5.3 shows a comparison of body weight, arm span and BMI between AIS 
patients and the normal population. AIS patients had a lower body weight, 
significantly lower BMI (p<0.01) and longer arm span (p<0.01). 
AIS patients were divided into two groups (normal and low) according to their mRNA 
expression level of melatonin receptors using the minimum value of normal controls 
as a reference line. Table 5.4 and Table 5.5 list the comparison of anthropometric 
parameters between the two groups for melatonin receptor l A and IB, respectively. 
For melatonin receptor lA , the z-scores between the normal and low expression 
groups were similar and there was no significant difference. Whereas for IB, 
patients wi th low expression had a significantly longer arm span (p=0.036) but there 
was not significant difference in body weight and BMI. 
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5.4 Discussion 
In this study, a quantitative difference in both protein and mRNA expression of 
melatonin receptor IB was found between AIS patients and normal controls. The 
expression of melatonin receptor IB (MTNRIB) was significantly lower in girls wi th 
AIS where that of melatonin receptor l A (MTNRIA) was similar between AIS patients 
and normal controls. In the previous study by Man et al. (334), MTNRIB protein 
could not be detected in some AIS patients while MTNRIA was present in all subjects. 
The result of the present study suggested that AIS had a lower protein and mRNA 
expression level of MTNRIB than control and the difference is likely to be 
quantitative rather than qualitative as suggested in the study by Man et al. (334). 
The discrepancy in the results of the two studies could be explained by the 
experimental procedures. In both studies, Western blotting was adopted for the 
detection of protein expression. The appearance and intensity of the band greatly 
depends on the choice of antibodies, the method of transfer of protein from gel to 
membrane and the signal development method and time. The antibodies used in the 
two studies were different and it was possible that the antibodies used in this study 
were more sensitive and could readily detect the epitomes of melatonin receptors 
exposed on the Western blotting membrane while the ones used previously (334) 
could not. The t ime for signal development could also greatly affect the band 
intensity. The development t ime in the study by Man et al. might be too short for 
the band of low intensity to appear. All these could explain why Man et al. (334) 
observed that some patients had undetectable MTNRIB and interpreted that the 
difference in expression between AIS patients and normal controls was qualitative. 
Besides, real t ime PGR was also performed in this study, which allowed the detection 
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of any quantitative difference in melatonin receptors expression and ruled out the 
total absence of MTNRIB expression in AIS girls. Nevertheless, the results of both 
studies were in concordant that there is abnormality in the expression of MTNRIB in 
the osteoblasts of AIS patients. 4 out of 13 AIS patients (31%) were found to have 
undetectable MTNRIB protein in the study by Man et al. (334) and a comparable 
number of AIS patients (12 out of 41 (29%)) had a lower MTNRIB mRNA expression 
as shown by the quantitative Real Time PGR results. 
The lower mRNA expression of MTNRIB in AIS girls indicated that its abnormal 
protein expression was due to upstream events instead of intermediate events like 
translation or protein turnover rate. The study of Qiu et al. (92) disclosed a single 
nucleotide polymorphism (SNP) at the promoter region of MTNRIB gene to be 
associated with the occurrence of AIS. They suggested that this might affect the gene 
expression of MTNRIB. This may account for the lower mRNA expression of MTNRIB 
of AIS patients found in this study. Yet, the results of Qiu et al. could not be 
reproduced by the studies from other research groups (100, 284, 285). This may be 
due to different ethnic groups, sample size, and selection criteria. The subjects 
recruited for the studies by Nelson et al. (285) and Morocz et al. (100) were 
Caucasian and Hungarian, respectively. It is known that the ratio of combinations of 
that SNP of interest is different among different ethnics (HapMap). In the study of 
Shyy et a/.(284), only 180 AIS patients and 180 normal controls were recruited, 
which was much smaller than the sample size of 814 AIS patients and 651 controls in 
the study by Qiu et o/.(92). It is known that small sample size in genetic association 
study could easily produce false results. These may explain the negative results by 
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other research groups. Besides mutations or SNPs of the gene, other upstream 
events such as transcription, pre-mRNA processing (splicing, polyadenylation), and 
mRNA stability all affect the level of mRNA. Slominiski et al. (338) once reported the 
presence of aberrantly spliced mRNA of MTNRIB in the pituitary. These aberrant 
mRNAs were shorter, wi th some missing sequence. They could not be translated 
correctly into protein and may not be detected by PGR because of the specificity of 
the primer. This may be one of the possible explanations for the lower mRNA and 
protein expression in AIS patients. 
The clinical phenotypes of recruited AIS patients were evaluated in this study. Similar 
to the results f rom previous studies (131, 161), AIS patients have longer arm span, 
lower body weight and BMI. Moreover, the patients wi th lower MTNRIB mRNA 
expression were found to have a significantly longer arm span than the patients wi th 
normal expression. A previous study on melatonin receptor expression in AIS 
patients by Man et al. (334) discovered that ones with undetectable MTNRIB also 
had an abnormal response of proliferation towards melatonin. Similarly, the results 
f rom the functional assay performed by Moreau et al. (281) also suggested that 
there was a differential melatonin signaling dysfunction in AIS patients. The authors 
suggested that the dysfunction was due to abnormal coupling of G-protein. The 
present result raised another speculation that the abnormalities in melatonin 
receptor expression could also lead to signaling dysfunction and might be associated 
with disproportional membranous-endochondral ossification and the abnormal bone 
growth in AIS. It has been reported that melatonin has a role in bone growth and 
metabolism (224, 257, 325). The hormone also has an effect on growth hormone, 
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the main regulator of growth during puberty. The present results further confirmed 
the role of melatonin in growth and scoliosis. Melatonin also promotes osteoblast 
proliferation, differentiation (257) and bone mineralization (224). Any abnormal 
expression in melatonin receptors in AIS patients could affect melatonin signaling 
which might be related to the general osteopenia in AIS girls. 
A pilot study on the expression pattern of MTNRIA and IB of AIS patients was also 
carried out. The localization of melatonin receptors has been studied previously and 
they are expressed on both cell membrane and nuclear membrane (339). Similar to 
the results f rom the study by Moreau et al. (281), no significant difference was found 
in the expression pattern of both melatonin receptors between AIS and controls in 
this experiment. However, the results displayed here seemed to be slightly deviated 
f rom that of the previous study (335) in terms of signal intensity and the expression 
pattern of the receptors. This might be explained by various reasons from the choice 
of antibodies to experimental conditions such as development t ime, 
permeabilization status, etc. It was clearly shown in Figure 5.11 and Figure 5.12 that 
MTNRIA and IB expressed on both cell membrane and nucleus in both AIS and 
normal control. Yet, the expression pattern of two melatonin receptors was very 
different as MTNRIB seemed to aggregate to form condensed clusters when l A was 
evenly distributed inside the nucleus. From previous studies reporting that different 
receptors can translocate to nucleolus (340-343), it is reasonable enough to 
speculate that MTNRIB was contained within the nucleolus. Nucleolus is responsible 
for ribosome transcription and assembly (344). Though the exact functions of 
MTNRIB in nucleolus requires further investigation, its localization inside the 
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nucleolus suggested that it might take part in the ribosome synthesis process and 
the expression level of MTNRIB could hence affect the ribosome production. 
Ribosomes are essential in protein synthesis. The lower MTNRIB expression in the 
osteoblasts of AIS patients might alter the nucleolus function and consequently 
protein synthesis and proper cell functions. 
Melatonin receptors belong to the G-protein coupled receptor (GPCR) family. 
Previous studies on the expression of GPCRs wi th heterologous system in cell lines 
(345) suggested that many, if not all, GPCRs form homo- and/or hetero-oligomers 
(346). The dimer-/oligo-merization may affect the functions of the receptors, such as 
G-protein coupling (345), and hence affecting downstream signaling. However, no 
observable co-localization of the two receptors was found in this study. They are 
distributed on the membrane surface wi thout overlapping and the 
heterodimerization of melatonin receptor on transfected cell line described in 
previous studies (347, 348) was not observed here. This may be due to the 
difference in cell type and the low expression of melatonin receptors in osteoblasts 
which do not favor the formation of heterodimer as suggested in the previous 
studies (347, 348). Though heterodimers of melatonin receptors was not observed in 
this study, the possibility of homodimers in the human osteoblasts could not be 
ruled out. Based on the image obtained on cell membrane, the range of the signal 
area of MTNRIA was much greater than MTNRIB. Therefore, the author speculated 
that MTNRIA might form homodimers in the present study. If the previous study 
suggested that MTNRIB formed heterodimer preferentially (348) the present results 
suggested the other way that MTNRIB did not form heterodimer with MTNRIA in 
128 
osteoblasts. Thus, further investigations are required to clarify the discrepancy 
between different studies. 
In this study, it was found that the expression of MTNRIB was abnormal in AIS 
patients. Both their protein and mRNA expression of MTNRIB was significantly lower 
than normal controls and the difference was quantitative rather than qualitative. 
However, not all the AIS patients showed a low expression of MTNRIB, implying the 
heterogeneity of the patients. With the previous evidences that melatonin receptor 
expression is related to proliferation of osteoblasts as well as clinical phenotypes 
such as arm span as found in this study, it could be deduced that the abnormal 
expression of melatonin receptor in these AIS patients affects bone growth and 
hence leads to abnormal growth as described in previous chapters. The localization 
study of melatonin receptors also provided new insight into the understanding of its 
dimerization and other possible function in osteoblasts. 
129 
I  B 
“  ^  ,  ^  ^  ^ 





 A  -
V.. •  •  -  ..  .  一、 -/I  * /  .  ::  一 . \  :  “ 
\i  .〜二  T  \  : H 
^
 
Figure 5.1 Isolation of Osteoblast and Cell Culture 
Trabecular bones from the biopsies were minced into small pieces (as pointed) and 
plated onto a 6-well culture plate (Figure 5.1A). The bone fragments were cultured in 
DMEM supplemented wi th 10% FBS and 1% PSN. Figure 5. IB shows the primary cell 
culture f rom the bone pieces of one of the subjects. Cells were harvested for 
assessment when they reached confluence (Figure 5.1C). 
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Figure 5.2 Validity of Antibodies by Co-immunoprecipitation 
The specificity of antibodies was tested using different antibodies (a gift f rom Prof. 
Fraschini (336)). The absence of non-specific bands proves the validity of the 
antibodies and the experiments. 
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Figure 5.3 Full length images of Western Blotting 
Figure 5.3A, B, C show the full-length images of Western blotting of melatonin 
receptor lA , IB and P-actin respectively. The absence of non-specific bands and the 
similar weight as shown in co-immunoprecipitation proves that the bands 
corresponds to the target protein. 
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Figure 5.4 Representative Images of Protein Expression of Melatonin Receptors in 
Osteoblasts of Normal Controls. 
Cells isolated from normal controls were cultured until confluence. Cells were then 
collected and lysed for analysis of protein expression of melatonin receptor l A and 
IB. Beta-Actin was used as an internal control and protein from MG63 was used for 
the calculation of relative intensity. All the normal controls showed the presence of 
melatonin receptor l A and IB. 
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Figure 5.5 Representative Images of Protein Expression of Melatonin Receptors in 
Osteoblast of AIS Patients. 
Cells isolated f rom normal controls were cultured until confluence. Cells were then 
collected and lysed for analysis of protein expression of melatonin receptor l A and 
IB. Beta-actin was used as an internal control and protein from MG63 was used for 
the calculation of relative intensity. It was found that the relative intensity of 
melatonin receptor IB of AIS patients was significantly lower than that of normal 
while no difference was observed for the relative intensity of melatonin receptor lA . 
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Figure 5.6 Relative Intensity of Protein Expression of Melatonin Receptor lA. 
The protein expression of melatonin receptor l A was quantified by relative intensity 
of each band. Relative intensity was calculated using MG63 as reference after 
correction with beta-actin. There was no significant difference in the protein 
expression of melatonin receptor l A of osteoblasts between AIS patients (n=25) and 
normal controls (n=5). (p=0.81) 
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Figure 5.7 Relative Intensity of Protein Expression of Melatonin Receptor IB. 
The protein expression of melatonin receptor IB was quantified by the relative 
intensity of each band. Relative intensity was calculated using MG63 as reference 
after correction with beta-actin. The protein expression of melatonin receptor IB of 
osteoblast was found to be significantly lower in AIS patients (n=24) than normal 
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Log of Relative Quantification of MTNRIB (Exon Region) 
Figure 5.8 Correlation of the results of Relative Quantification of Melatonin 
Receptor I B using TaqMan Expression Assay from different regions. 
The log of relative quantification values using the custom made expression assay 
f rom extracellular region was plotted against that of the pre-made assay from exon 
region. The correlation of the two values was high (R^=0.6183) and significant 
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Figure 5.9 Relative Quantification mRNA Expression of Melatonin Receptor lA. 
The mRNA level of Melatonin Receptor l A was measured by RT-PCR using TaqMan 
with a pre-made primer which flanks the across exon region of melatonin receptor 
lA . The results were quantified using the relative value to a control sample. There 
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Figure 5.10 Relative Quantification of mRNA Expression of Melatonin Receptor IB. 
The mRNA level of melatonin receptor IB was measured by RT-PCR using TaqMan 
with a pre-made primer across the extracellular region of melatonin receptor IB. 
The results were quantified using the relative value to a control sample. Significant 
difference was found in the mRNA expression of melatonin receptor IB between AIS 
(n=41) and normal controls (n=8) wi th AIS having a lower expression level (p=0.019). 
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Figure 5.11 Localization of Melatonin Receptors in Osteoblast of AIS Patients and 
Normal Controls. 
For both AIS patients (Figure 5.11A, C, E) and normal control (Figure 5.11B, D, F), 
melatonin receptor l A (Figure 5.11A, B) and IB (Figure 5.11C, D) were distributed 
evenly on the cell surface and co-localization of the two receptors was not observed 
(Figure 5 .HE, F). The area of the red signal obtained for melatonin receptor l A 
expression on cell membrane ranged from 0.29-0.45 whereas that of melatonin 
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Figure 5.12 Localization of Melatonin Receptors in Osteoblasts of AIS Patients and 
Normal Controls under Permeabilized Conditions. 
The expression pattern was similar for both AIS patients (Figure 5.12A, C, E) and 
normal controls (Figure 5.12B, D, F), Melatonin receptor l A (Figure 5.12A, B) was 
distributed evenly inside the nucleus Condensed clusters of melatonin receptor IB 
(Figure 5.12C, D) were observed inside the nucleus. Similarly, no co-localization of 
the two receptors was observed (Figure 5.12E, F). 
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Table 5.1 Clinical Data of AIS Patients 
Case Diagnosis " c u w Type Gender Age a t C o b b 
Number Pattern Surgery angle 
1 AIS Single Lumbar ^ 
Curve 
2 AIS Single Thoracic ^ ^ 
Curve 
3 AIS Double Thoracic - F 13.4 7 7 . 4 5 
Curve Lumbar 
4 AIS Single Thoracic F 1 9 . 8 
Curve 
5 AIS Double Thoracic - F 10.2 18-49 
Curve Thoracolumbar 
6 AIS Double Thoracic - F 17.9 21-52 
Curve Thoracic 
7 AIS Single Thoracic ~f ^ 
Curve 
8 AIS Double Thoracic - F 16A 44-43 
Curve Lumbar 
9 AIS Double Thoracic- F I 8 . 7 32-56 
Curve Lumbar 
10 AIS Triple Thoracic- " f i l 2 33-56-
Curve Thorac ic- 52 
Lumbar 
11 AIS Single Thoracic F ^ 
Curve 
12 AIS Double Thoracic- F 1 7 . 8 19-48 
Curve Lumbar 
13 AIS Double Thoracic - F 11.5 50-32 
Curve Lumbar 
14 AIS Double Thoracic - F 11.1 32-48 
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-Curve Thoracolumbar 
15 AIS Double Thoracic - F 11.23 30-52 
Curve Thoracolumbar 
16 AIS Double Thoracic - F 14.44 40 41 
Curve Thoracolumbar 
17 AIS Double Thoracic - F 1 3 . 6 51-34 
Curve Lumbar 
18 AIS Single Thoracic F 13.6 
Curve 
19 AIS Single Thoracic F 15.4 45 
Curve 
20 AIS Single Lumbar F 16.3 45 
Curve 
21 AIS Single Thoracic F 13.9 40 
Curve 
22 AIS Single Thoracolumbar F 1 4 . 6 41 
Curve 
23 AIS Double Thoracic - F 17.7 28-51 
Curve Thoracolumbar 
24 AIS Single Thoracolumbar F 13.4 ^ 
Curve 
25 AIS Double Thorac ic- F 14.0 49.58 
Curve Lumbar 
26 AIS Double Thoracic- F 13.5 42-43 
Curve Lumbar 
27 AIS Double Thorac ic- F 14.0 40-54 
Curve Lumbar 
28 AIS Single Thoracic F 9.8 ^ 
Curve 
29 AIS Double Thoracic- F 14.3 62-47 
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Curve Lumbar 
30 AIS Double Thorac ic- F 1 4 3 26-43 
Curve Lumbar 
31 AIS Double Thorac ic- F 1 2 . 7 56-28 
Curve Lumbar 
32 AIS Double Thoracic - F 14.7 26-48 
Curve Thoracolumbar 
33 AIS Double Thorac ic- F 15.3 32-46 
Curve Lumbar 
34 AIS Double Thorac ic- F 13.9 48-44 
Curve Lumbar 
35 AIS Double Thorac ic- F 13.7 4 5 . 3 2 
Curve Lumbar 
36 AIS Double Thoracic - F 15.3 31-63 
Curve Thoracolumbar 
37 AIS Double Thoracic - F 19.6 38-60 
Curve Thoracolumbar 
38 AIS Double Thoracic - F 17.4 60-55 
Curve Thoracolumbar 
39 AIS Triple Thoracic- F 12.7 5 6 - 6 6 - ~ 
Curve Thoracolumbar- 32 
Lumbar 
40 AIS Double Thoracic - F 17.1 84-75 
Curve Thoracolumbar 
41 AIS Triple Thorac ic- F 12.9 22-64-
Curve Thoracolumbar- 33 
Lumbar 
AIS = Adolescent Idiopathic Scoliosis 
M = Male; F = Female 
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Table 5.2 Clinical Data of Normal Controls 
Case Type of Surgery Curve Pa t te rn「Gender Age 
Number 
1 Open Reduction and Internal NIL 
Fixation 
2 Open Reduction and Internal NIL ^ 
Fixation 
3 Open Reduction and Internal NIL F 13.5 
Fixation 
4 Open Reduction and Internal NIL F 18.2 
Fixation 
6 Right ACL Reconstruction NIL ~F 22.8 
7 Infective Spondylordiscitis NIL F 12.7 
8 Left ACL Reconstruction NIL ~m 24.7 
9 Left ACL Reconstruction NIL ~F 
ACL = Anterior cruciate ligaments 
M = Male; F 二 Female 
148 
Table 5.3 Clinical Evaluation of AIS Patients 
AIS patients (n=40) Age-adjusted p-value 
Mean 士 SD z-score 
Mean ± SD 
BW (kg) 46.46 ±6.36 -0.15 ±0.91 
BMI (kg/m') 18.37 ±2.16 -0.45 ±0.15 
Arm Span (cm) 158.96 ±6.13 0.41 ±0.83 <0.01** 
The z-score of body weight (BW), body mass index (BMI) and arm span of AIS 
patients were compared against the normal population by one sample Student's t-
test using 0 as reference value as the z-score of the normal population is 0. All data 
were expressed as mean 土 S.D. AIS patients had a significantly lower BMI* and 
longer arm span** (p<0.01). 
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Table 5.4 Correlation of Clinical Phenotypes of AIS Patients with the mRNA 
Expression of Melatonin Receptor lA. 
\ Group Low expression Normal expression p-value 
\ (< minimum RQ value of (> minimum RQ value 
\ normal control) of normal control) 
z-score of \ (n=6) (n=32) 
BW —-0.070 ± 0.62 -0.136 ±0.98 
BMI l 3 8 4 土 0.67 -0.429 ± 0.98 
Arm Span 0.471 ±0.28 0.412 ±0.92 o ^ 
~‘ 1 
^ 15.2 ±1.5 15.3 ±2.1 [ o ^ 
The AIS patients were divided into groups according to their mRNA expression level 
of melatonin receptor l A and their anthropometric parameters (body weight (BW), 
body mass index (BMI) and arm span) were compared by Student's t-test. All data 
were expressed as mean 土 S.D. The z-scores and age between two groups were 
similar. 
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Table 5.5 Correlation of Clinical Phenotypes of AIS patients with mRNA Expression 
of Melatonin Receptor IB. 
\ Group Low expression Normal expression p-value 
(< minimum RQ value of (> minimum RQ value 
normal control) of normal control) 
z-score of ( n = l l ) (n=27) 
BW 0.112 ± 1.13 -0.223 ±0.83 0.318 
BMI -0.464 ±1.18 -0.405 ± 0.83 0.861 
Arm Span 0.870 ±0.86 0.238 ± 0.79 0.036* 
Age 15.7 ±2.0 15.1 ± 1.9 0.414 
The AIS patients were divided into groups according to their mRNA expression level 
of melatonin receptor IB and their anthropometric parameters (Body weight (BW), 
body mass index (BMI) and arm span) were compared by Student's t-test. All data 
were expressed as mean 土 S.D. Patients wi th low expression of melatonin receptor 
IB had a significantly longer arm span (*p=0.036). The z-scores for other parameters 
and the age were similar between two groups. 
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Chapter 6 Summary and Overall Discussion 
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6.1 Study Flowchart 
Background 
银 Adolescent idiopathic scoliosis is a complex three-dimensional structural 
deformity of the spine occurring most commonly in adolescence with a 
prevalence of 4%. 
银 Current treatments, including observation, bracing and surgical correction, are 
not totally satisfactory and are associated with different morbidity and 
complications. The ultimate remedy for progressive AIS patients requires proper 
understanding of the etiopathogenesis and thus specific and appropriate 
treatment regime. 
银 Genetic factors, abnormal skeletal growth, metabolic dysfunction, neurosensory 
disturbance, and biomechanical stress are the main groups that have been 
postulated to be associated with the etiopathogenesis of AIS. 
I I I " “ 
Previous Studies 
Abnormal skeletal growth 
银 Cross-sectional studies showed that AIS girls are found to be taller, leaner and 
have a longer arm span than normal controls. 
傘 Peak height velocity and growth rate of AIS girls are different from controls and 
may be associated wi th the development of scoliosis. 
银 Relative anterior spinal overgrowth due to uncoupled endochondral-
membranous bone formation is found in AIS girls 
Metabolic Dysfunction 
银 Experimental animal models of pinealectomized chicken and melatonin-deficient 
mice were found to develop similar spinal deformity. 
银 Melatonin promotes the proliferation, differentiation and mineralization of 
human osteoblasts in a dose-dependent manner. 
银 Melatonin signaling pathway dysfunction is present in osteoblasts isolated from 
severe AIS patients. 




银 Abnormal skeletal growth is observed in AIS girls 
银 Melatonin plays a role in bone formation and remodeling and scoliosis 
development 
傘 Melatonin signaling dysfunction exists in AIS patients due to abnormal receptor 
expression 
Hypothesis: 
There is abnormal growth in AIS which is related to melatonin signaling dysfunction 
Objectives 
1. To study the anthropometric parameter, skeletal growth and growth pattern of 
AIS girls, in comparison with normal female controls, by a cross-sectional and a 
longitudinal study 
2. To establish a local scoliotic chicken model induced by melatonin-deficiency for 
the investigation of abnormal growth 
3. To compare the protein and mRNA expression of melatonin receptor, between 
AIS patients and normal controls. 
•/•y. /.y.v.y. a /. /. /. z z x /. 
Research Question 1: 
Is there any systemic abnormality in skeletal growth in AIS girls? 
Methods: 
银 Cross-sectional and longitudinal study 
银 Anthropometric measurements (Body weight, height, arm span) 




银 Severe AIS patients have a longer arm span with delayed menarche. 
银 The growth patterns among control, moderate and severe AIS patients are 
different. 
傘 Severe AIS girls have a restricted growth at age 12, which then catches up and 
surpasses the normal controls with a higher skeletal growth rate, particularly in 
arm span; while moderate AIS girls have a longer arm span and greater corrected 
height consistently. 
Discussion: 
银 Systemic abnormality in skeletal growth exists in AIS girls. 
银 The arm span in severe AIS girls is longer and the growth pattern and growth rate 
are significantly different. 
银 Sustained the possibility of uncoupled endochondral-membranous ossification 
which leads to the skeletal growth abnormality 
傘 The potential of arm span as a predictive factor for the development of scoliosis. 
Jipg^--
Research Question 2: 
What is the role of skeletal growth in scoliosis development? 
Methods: 
傘 Chicken, a bipedal-animal, was pinealectomized to produce a melatonin-deficient 
condition. 
银 The anthropometric parameters (weight and length of tibia) were measured 
along with their growth till 5 weeks. 
傘 The development of the spine and scoliosis was monitored constantly. 
银 The growth pattern and growth rate pattern were described 
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Findings: 
银 All pinealectomized chickens but none in the sham-operated group developed 
scoliosis 
银 There was no significant difference in the weight and length of tibia between 
pinealectomized and sham chickens. 
傘 The growth rate pattern, in terms of rate of growth in length of tibia, was 
different between pinealectomized and sham chickens. All the pinealectomized 
chickens showed an abnormal M-shape-like growth while the sham chickens did 
not. 
傘 The M-shape-like growth appeared before the onset of scoliosis. 
^ ^ ~ 
Discussion: … 
傘 Pinealectomized chickens showed an abnormal growth rate pattern before the 
onset of scoliosis, indicating that the skeletal growth pattern is greatly related to 
the occurrence of scoliosis. 
银 Chickens developed scoliosis and showed abnormal skeletal growth under a 
melatonin-deficient condition, implying the importance of melatonin in scoliosis 
and the possible influence of melatonin on skeletal growth 
Research Question 3: 
Is there any abnormality in the expression of melatonin receptor in AIS girls? 
Methods: 
傘 Isolation of osteoblasts from AIS patients wi th corrective surgery and from 
normal controls during trauma-related surgery. 
傘 Investigation of protein and mRNA expression of melatonin receptors in 
osteoblasts by Western blotting and real t ime polymerase chain reaction 
银 Clinical evaluation of AIS patients 
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银 study of localization of melatonin receptors in osteoblasts by 
immunofluorescence labeling 
Findings: 
银 The protein and mRNA levels of melatonin receptor IB in AIS girls were shown to 
be significantly lower than normal control. The difference was quantitative rather 
than qualitative. 
傘 A group of patients wi th lower melatonin receptor IB expression had a 
significantly longer arm span 
傘 In this pilot study, both melatonin receptor l A and IB were expressed on cell 
membrane and nucleus. Melatonin receptor IB formed clusters inside the 
nucleus while l A did not. There was no difference in expression pattern between 
AIS and control. 
Discussion: — 
傘 Difference in protein and mRNA level of melatonin receptor IB may explain the 
previously reported melatonin signaling dysfunction in AIS girls. 
银 The longer arm span in a group of patients wi th lower melatonin receptor IB 
expression implied the association between melatonin signaling and longitudinal 
growth 
银 Not all the patients had lower expression of melatonin receptors than normal 
control, indicating a mixed group of patients within the AIS population 
傘 Clusters of melatonin receptor IB inside the nucleus suggested they were 
localized at the nucleolus. The localization of melatonin receptor IB implied it 
might have unique function, which might be related to nucleolus function. 
I ^ — — I 
Summary： ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ 
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Existence of skeletal growth abnormality in AIS patients, particularly the severe 
cases, in terms of the growth pattern. 
银 Abnormal growth rate pattern observed before the onset of scoliosis in a 
melatonin-deficient animal model implied the importance of melatonin on 
growth and scoliosis development 
傘 Abnormal expression of melatonin receptor in AIS patients which may lead to 
melatonin signaling and hence affect growth, as indicated by the longer arm span 
in these patients. 
傘 Role of melatonin signaling in skeletal growth and scoliosis development 
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6.2 Summary and Discussion 
Adolescent idiopathic scoliosis is a major spinal deformity in adolescence with 
unknown etiology. It is generally believed that etiopathogenesis of AIS is 
multifactorial. The current treatments are not satisfactory because of the lack of 
understanding of the disease. It is therefore essential to investigate on the 
etiopathogenesis of AIS to aid the development of better treatments. This present 
study aimed to investigate the abnormal growth of AIS patients and its possible 
relationship with melatonin signaling dysfunction. The key findings of this study are: 
1) Abnormal skeletal growth rate existed in AIS patients; 2) The growth patterns of 
girls with severe and moderate AIS were different from normal controls; 3) A 
scoliotic model with abnormal growth was successfully established with locally bred 
chicken by pinealectomy; 4) An abnormal growth rate pattern was observed before 
the onset of scoliosis in the scoliotic chicken model; 5) The expression level of 
melatonin receptor I B was significantly lower in AIS; 6) The expression of melatonin 
receptor I B was related to the arm span in AIS patients. 
In the cross-sectional study on the anthropometry of AIS patients, it was found that 
AIS girls had a longer arm span, greater corrected body height, lower body weight 
and BMI, and delayed menarche. With the consideration of the delay menarche In 
AIS girls and the possible effect of menarche on growth (349), further analysis with 
adjustment for onset of menarche was preformed. It was found that the growth rate 
of severe AIS girls was faster than that of moderate AIS girls and normal controls 
after adjusted for sexual maturity and their growth patterns were different. The 
magnitude of growth rate seems to be related to the curve severity of AIS where 
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severe AIS girls had highest growth rate during aged 12-16. Furthermore, moderate 
and severe AIS were taller than normal girls at the time of menarche. Assuming that 
they had similar height during the very early childhood, it is speculated that AIS girls 
with different curve severities could have different growth patterns. In moderate AIS 
girls, the rapid growth phase might happen before menarche and the growth slowed 
down after menarche; whereas in severe AIS girls, the rapid growth phase happened 
before menarche and persisted after menarche. This observation is in line with the 
study by Loncar-Dusek et al. (159) showing that faster growth velocity during 
puberty is likely to develop scoliosis. In addition to growth rate changes in AIS girls, 
their onset of menarche was also delayed. The relationship between delayed 
menarche and changes in growth pattern is warranted for further investigation. It is 
also speculated that growth rate of AIS might also be a determining factor for curve 
severity. However, similar to other previous studies on the growth of AIS patients 
(131, 290), the subjects were recruited after onset of scoliosis, and the growth 
pattern and rate before the onset had not been explored. 
To circumvent the effort to conduct a large scale screening-type clinical study with 
extensive longitudinal follow-up for children growth rate before the onset of 
scoliosis, a scoliosis chicken animal model was adopted in this study to investigate 
the early growth before scoliosis development and to understand the relationship 
between AIS and abnormal growth. Pinealectomy could successfully induce scoliosis 
in a locally bred chicken (Kamei chicken) and none of the sham-operated chickens 
developed scoliosis. The pinealectomized chicken developed scoliosis within 13 days 
post-op). Besides, the pinealectomized chickens showed a M-shape-like growth rate 
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pattern (a sudden drop in growth rate followed by an increase with two peaks) right 
before the onset of scoliosis (starting from Day 9 post-op), which could not be 
observed in any of the sham chickens. This is the first report on the difference in 
growth rate pattern in a scoliotic animal model and the abnormal growth could be 
observed before the onset of scoliosis. It is noteworthy that there was one 
exceptional pinealectomized chicken which developed scoliosis on Day 23 post-op. It 
exhibited a double peak of the M-shape-like growth shifted together with the 
occurrence of scoliosis (Day 13 post-op). Its scoliosis was also relatively mild in terms 
of curve progression rate. The results implied that an abnormal growth pattern is 
tightly coupled with the occurrence and development of scoliosis. In human, the 
occurrence and progression of scoliosis were shown to be closely associated with the 
skeletal growth in AIS girls (35, 159). The observation in the scoliosis chicken model 
further supported that growth has an important role in scoliosis development as 
described in the longitudinal study. The existence of an abnormal growth rate 
pattern before the onset of scoliosis in chickens also warranted a study on the early 
growth of adolescent with longitudinal follow up for scoliosis development. 
Scoliosis of chickens was induced by pinealectomy, which would generate a 
melatonin-deficient condition. This indicated that melatonin could be an important 
factor in skeletal growth and growth pattern and subsequently the development of 
scoliosis during the critical period. It substantiates the notion that melatonin-
signaling deficiency is closely linked to the etiopathogenesis of AIS. However, results 
from previous studies on melatonin level in AIS girls still remain controversial (276, 
278) and it was recently raised that melatonin signaling deficiency existed in AIS girls 
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and was associated with abnormal expression of melatonin receptors (334). 
Melatonin receptors l A (MTNRIA) and I B (MTNRIB) are the main mediators of 
i 
melatonin's effect in human. In this study, it was found that both the protein and 
mRNA expression of MTNRIB were significantly lower in AIS patients. The difference 
in expression of MTNRIB was quantitative. For MTNRIA, the protein and mRNA 
levels were similar in AIS and normal. The lower expression of MTNRIB in some of 
the AIS patients implied that their melatonin signaling might be affected. 
The clinical evaluation on these patients echoed with the cross-sectional study that 
they had lower body weight, BMI and arm span. Moreover, it was found that the 
patients with low expression of MTNRIB had a significantly longer arm span. 
Together with the observation of an abnormal growth in the melatonin-deficient 
scoliotic chickens, the results implied that melatonin signaling is associated with 
growth. It also suggested that the signaling deficiency in the AIS patients was 
probably via MTNRIB. It has to be noted that not all the AIS patients had a lower 
expression of MTNRIB and longer arm span than control, which demonstrated the 
heterogeneity of the disease. 
In summary, the present study showed that abnormal growth occurred in AIS 
patients, particularly the severe ones, with the evidences from the study on the 
anthropometry of moderate and AIS patients, which represented one of the very 
few longitudinal studies. The abnormal growth is closely associated with the 
occurrence and development of scoliosis, as shown by, for the first time, the 
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existence of abnormal growth rate pattern before the onset of scoliosis in a newly 
I established local scoliotic chicken model. The melatonin-deficient condition 
produced by pinealectomy in the chicken model suggested that abnormal growth 
and occurrence of scoliosis was associated with melatonin signaling dysfunction. 
] 
Further investigation on melatonin receptors in osteoblasts of AIS patients revealed 
a lower expression on MTNRIB. The patients with lower MTNRIB expression had a 
longer arm span, indicating that their growth was indeed affected and provided 
another piece of evidence that growth is tightly coupled with scoliosis and melatonin 
signaling plays an important role in the occurrence and development of scoliosis. 
6.3 Limitations and Further Studies 
The study of anthropometry of AIS patients (Chapter 3) was one of the very few 
longitudinal studies. However, the AIS patients were recruited after their onset of 
scoliosis and data on their earlier growth was not available A further longitudinal 
prospective study was needed to investigate the growth of AIS patients before the 
occurrence of scoliosis. 
In the animal study (Chapter 4), scoliosis was induced by pinealectomy to produce a 
melatonin-deficient condition. To verify that the occurrence of scoliosis was solely 
due to the low level of melatonin but not the consequence of the surgery or other 
factors, a group of pinealectomized chickens with melatonin injection or supplement 
is needed. These are the limitations of this experiment and this group certainly has 
to be included in future investigations. 
163 
The results suggested that melatonin might have a role in both growth and scoliosis 
I development. The author speculated that the effect on growth by melatonin was via 
its influence on the circadian rhythm and growth hormone. However, studies 
associating melatonin, growth hormone and AIS are very few and their relationship 
I is yet to be proved. Therefore, studies on growth hormone in this model, and other 
possible factors, such as the effect of melatonin and circadian rhythm on growth 
plate have to be carried out to understand the underlying mechanism of how 
melatonin could affect growth and hence occurrence of scoliosis. 
The animal study aimed to study the early growth before scoliosis and lasted for 5 
weeks only. The difference in BMD in pinealectomized chicken, as reported in 
previous study (322), was not found. The experiment could be extended for a longer 
period (8 weeks or above) in the future, so to allow the investigation of melatonin on 
bone formation or acquisition. 
Chapter 5 studied the expression of melatonin receptors in the osteoblast of AIS 
patients and normal control. Because of practical and ethical reasons, the gender of 
normal subjects consisted of both male and female and the age spectrum was older 
than AIS patients. The level of hormone affecting bone metabolism, such as 
estrogen, might be very different between the patients and normal subjects. 
However, this was an in vitro study and these differences were overcome by 
culturing the cells under the same conditions. 
Although the expression of MTNRIB was found to be significantly lower in AIS 
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patients, the direct effect of this phenomenon on the osteoblast, such as 
proliferation and differentiation was not investigated. To understand how MTNRIB 
I expression could affect osteoblast function and hence bone growth or bone quality, 
a functional test and also a correlation between MTNRIB expression and bone 
mineral density (BMD) would be necessary in the subsequent studies. 
i 
The clinical evaluation of these patients showed that patients with lower MTNRIB 
expression had a longer arm span. Yet, the studies on melatonin and longitudinal 
bone growth are very few. Further studies in this aspect, such as the effect of 
melatonin on growth plate and the process of longitudinal growth (e.g. 
endochondral ossification) are worth undertaking. 
The localization of melatonin receptors was carried out by immunofluorescence 
labeling. Quantification using this method was not feasible in this study because of 
the different conditions (e.g. incubation time) used for each sample. Therefore, 
Western blotting was used instead for the semi-quantification of melatonin 
receptors. The results suggested that MTNRIB might be contained within the 
nucleolus. However, the reason for its special localization and its function inside the 
nucleolus is still unknown. It is essential to verify in the future the exact location of 
MTNRIB and its other possible functions. The greater signal size of MTNRIA 
indicated that it might be in the form of homodimer, but the observation may be 
due to the insufficient resolution and other methods have to be adopted to confirm 
the existence of homodimer and its possible role in melatonin signaling. 
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